{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"],"fields":{"title":{"boost":1000.0},"text":{"boost":1.0},"tags":{"boost":1000000.0}}},"docs":[{"location":"","title":"About","text":""},{"location":"#assess-protein-dynamics-post-translational-modifications-through-elixir-belgium-node-services-b2btools-scop3p","title":"Assess protein dynamics &amp; post-translational modifications through ELIXIR Belgium Node services: B2BTools &amp; Scop3P","text":""},{"location":"#lesson-overview","title":"Lesson overview","text":"<p> Description The breakthrough of AlphaFold2 delivered structural models for nearly all proteins lacking experimental structures, opening new avenues to interrogate both sequence and structure. However, these models capture static snapshots rather than the dynamic conformational ensembles that govern protein behaviour. </p> <p></p> <p>The Bio2Byte Tools, published as B2BTools, is  a suite of sequence-based predictors for unveiling the biophysical properties hidden in the amino acid language with ease: backbone dynamics, early folding events, disordered positions among other features. Developed by the lab led by Prof. Dr. Wim Vranken, this online platform is part of the ELIXIR Belgium node services. In parallel to this suite of tools, Scop3P, another ELIXIR Belgium node service, will allow you to  explore and understand the impact of phospho-sites on human protein structure and function. It can serve as a springboard for researchers seeking to analyse and interpret a given phosphorylation site or phosphoprotein in a structural, biophysical, and biological context.</p> <p></p> <p> Prerequisites Basic knowledge on proteins, protein structures are a plus. Python language skills are recommended (not mandatory) to follow the Jupyter Notebook examples on Google Colab platform.</p> <p></p> <p> Learning Outcomes: By the end of the course, learners will be able to:  </p> <ol> <li>Calculate and analyse protein biophysical profiles for sequence-based data. </li> <li>Perform exploratory structural analysis combining the AlphaFold predictions with biophysical profiles generated by the B2BTools.  </li> <li>Compare the impact on protein dynamics by introducing mutations with B2BTools.  </li> <li>Able to correlate biophysical properties to post-translational modifications (PTMs).  </li> </ol> <p></p> <p> Target Audience: All scientists and technical staff, all interested in working with protein dynamics, all researchers and industry professionals.  </p> <p></p> <p> Level: Beginners.</p> <p> License: Creative Commons Attribution 4.0 International License </p> <p> Funding: This project has received funding from VIB.  </p>"},{"location":"#authors","title":"Authors","text":"<p>Pathmanaban Ramasamy</p> <p> CompOmics/UGent, ELIXIR-BE </p> <p>Adri\u00e1n D\u00edaz</p> <p> Bio2Byte/VUB, ELIXIR-BE </p>"},{"location":"#citing-this-lesson","title":"Citing this lesson","text":"<p>Please cite as:</p> <ol> <li>Pathmanaban Ramasamy, Adri\u00e1n D\u00edaz (2026). Training Material: Assess protein dynamics &amp; post-translational modifications. Zenodo. https://doi.org/10.5281/zenodo.18242776.</li> <li>Jose Gavalda-Garcia, Adri\u00e1n D\u00edaz, Wim Vranken. (2024). bio2Byte Tools deployment as a Python package and Galaxy tool to predict protein biophysical properties. Bioinformatics, Volume 40, Issue 9, September 2024, btae543. doi.org/10.1093/bioinformatics/btae543 <sup>1</sup>.</li> <li>Luciano Porto Kagami, Gabriele Orlando, Daniele Raimondi, Francois Ancien, Bhawna Dixit, Jose Gavald\u00e1-Garc\u00eda, Pathmanaban Ramasamy, Joel Roca-Mart\u00ednez, Konstantina Tzavella, Wim Vranken, b2bTools: online predictions for protein biophysical features and their conservation, Nucleic Acids Research, Volume 49, Issue W1, 2 July 2021, Pages W52\u2013W59. doi.org/10.1093/nar/gkab425 <sup>2</sup>.</li> <li>Pathmanaban Ramasamy, Demet Turan, Natalia Tichshenko, Niels Hulstaert, Elien Vandermarliere, Wim Vranken, &amp; Lennart Martens. (2020). Scop3P: A Comprehensive Resource of Human Phosphosites within Their Full Context.  Journal of Proteome Research 2020 19 (8), 3478-3486. 10.1021/acs.jproteome.0c00306 <sup>3</sup>.</li> </ol>"},{"location":"#training-template","title":"Training Template","text":"<p>Please cite as:</p> <ol> <li>Geert van Geest, Elin Kronander, Jose Alejandro Romero Herrera, Nadja \u017dlender, &amp; Alexia Cardona. (2023). The ELIXIR Training Lesson Template - Developing Training Together (v1.0.0-alpha). Zenodo. doi.org/10.5281/zenodo.7913092 <sup>4</sup>. </li> </ol>"},{"location":"#setup","title":"Setup","text":"<p>To run this course you need to:</p> <ul> <li>Have in mind a TOKEN that will be used to access your B2BTools predictions.</li> <li>A Google Account (in general, your <code>@gmail.com</code> email) to login on Google Colab.</li> </ul> <ol> <li> <p>Jose Gavalda-Garcia, Adri\u00e1n D\u00edaz, and Wim Vranken. Bio2byte tools deployment as a python package and galaxy tool to predict protein biophysical properties. Bioinformatics (Oxford, England), 40(9):btae543, September 2024. URL: https://europepmc.org/articles/PMC11873786, doi:10.1093/bioinformatics/btae543.\u00a0\u21a9</p> </li> <li> <p>Luciano Porto Kagami, Gabriele Orlando, Daniele Raimondi, Francois Ancien, Bhawna Dixit, Jose Gavald\u00e1-Garc\u00eda, Pathmanaban Ramasamy, Joel Roca-Mart\u00ednez, Konstantina Tzavella, and Wim Vranken. B2btools: online predictions for protein biophysical features and their conservation. Nucleic Acids Research, 49(W1):W52\u2013W59, 05 2021. URL: https://doi.org/10.1093/nar/gkab425, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W52/38842326/gkab425.pdf, doi:10.1093/nar/gkab425.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Demet Turan, Natalia Tichshenko, Niels Hulstaert, Elien Vandermarliere, Wim Vranken, and Lennart Martens. Scop3p: a comprehensive resource of human phosphosites within their full context. Journal of proteome research, 19(8):3478\u20143486, August 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00306, doi:10.1021/acs.jproteome.0c00306.\u00a0\u21a9</p> </li> <li> <p>Geert van Geest, Elin Kronander, Jose Alejandro Romero Herrera, Nadja \u017dlender, ELIXIR Training Coordination Team, and Alexia Cardona. The elixir training lesson template - developing training together. May 2023. URL: https://doi.org/10.5281/zenodo.7913092, doi:10.5281/zenodo.7913092.\u00a0\u21a9</p> </li> </ol>"},{"location":"course_schedule/","title":"Course schedule","text":"<p>The content of this training is designed to take a full working day. Learnings will be integrated with practical exercises for each conceptual section using interactive web-based platforms:</p>"},{"location":"course_schedule/#agenda","title":"Agenda","text":"Start End Topic 08:45 09:00 Welcome and setting up the working environments 09:00 09:30 Introducing the biological context 09:30 10:30 Building biological profiles 10:30 10:45 Coffee break 10:45 12:00 Building biological profiles (cont.) 12:00 13:30 Lunch break 13:30 15:00 Introducing Scop3P 15:00 15:15 Coffee break 15:15 16:15 Combining PTM annotations to biophysical properties 16:15 16:30 Coffee break 16:30 16:50 Closing 16:50 17:00 Following up this training"},{"location":"follow_up_training/","title":"Follow up training","text":"<p>This page is intended to help participants apply the concepts and workflows introduced in this course to their own proteins and research questions.</p>"},{"location":"follow_up_training/#11-biophysical-properties","title":"1.1 Biophysical properties","text":"<p>Biophysical properties such as early folding propensity, disorder probability, and backbone dynamics provide valuable complementary information to sequence and structure data. These features help researchers identify residues and regions that are important for protein folding, stability, and regulation.</p> <p>By analysing these properties, it becomes possible to distinguish between regions that are structurally stable and regions that are flexible, transient, or condition-dependent. This distinction is especially relevant for signaling proteins, where function often depends on conformational changes rather than rigid structures.</p>"},{"location":"follow_up_training/#111-distribution-channels-of-the-b2btools","title":"1.1.1 Distribution channels of the B2BTools","text":"<p>There are multiple alternatives to use the predictors either locally or using cloud resources:</p>"},{"location":"follow_up_training/#1111-local-installation","title":"1.1.1.1 Local installation","text":"<ol> <li>Via the Python Index (<code>pip</code>) visit package page: <code>pip install b2bTools</code></li> <li>Via the Conda package manager (<code>conda</code>) visit package page: <code>conda install bioconda::b2btools</code></li> <li>Via containers (<code>biocontainers</code>) visit containers page: <ol> <li>Docker: <code>docker pull quay.io/biocontainers/b2btools:3.0.7--py310h8ea774a_2</code></li> <li>Singularity: <code>singularity run https://depot.galaxyproject.org/singularity/b2btools:3.0.7--py310hdbdd923_0</code>.</li> </ol> </li> </ol>"},{"location":"follow_up_training/#1112-cloud-usage","title":"1.1.1.2 Cloud usage","text":"<ol> <li>Online Notebooks on Google Colab: visit the public repository on Github</li> <li>Using Galaxy platform for GUI oriented executions:<ol> <li>Belgian server: usegalaxy.be</li> <li>European server: usegalaxy.eu</li> <li>Australian server: usegalaxy.org.au</li> </ol> </li> </ol>"},{"location":"follow_up_training/#112-about-bio2byte","title":"1.1.2 About Bio2Byte","text":"<p>This group is led by Prof. Dr. Wim Vranken and it is part of the Vrije Universiteit Brussel in Belgium. </p> <p>Additional information about the Bio2Byte lab can be found at:</p> <ul> <li>Home page: https://bio2byte.be </li> <li>Latest publications: https://bio2byte.be/publications</li> <li>Tools: https://bio2byte.be/tool/</li> <li>Databases: https://bio2byte.be/database/</li> </ul>"},{"location":"follow_up_training/#12-post-translational-modifications-ptms","title":"1.2 Post-translational modifications (PTMs)","text":"<p>Post-translational modifications (PTMs) play a critical role in regulating protein activity, localization, interactions, and stability. Both ScoP3P <sup>1</sup> and ScoP3PTM aim to provide biological and structural context to these modifications, moving beyond simple site annotation.</p>"},{"location":"follow_up_training/#121-scop3p","title":"1.2.1 ScoP3P","text":"<p>One of the most extensively studied PTMs is protein phosphorylation. Advances in high-throughput mass spectrometry (MS/MS) have led to a rapid increase in publicly available phosphoproteomics data. However, many existing phosphorylation resources focus mainly on sequence information and phosphosite positions, often lacking structural and biophysical context.</p> <p>Structural information is particularly important when addressing a key biological question: how to distinguish functional phosphosites from non-functional or incidental ones.</p> <p>ScoP3P is a database of human phosphosites derived from public proteomics data. Each phosphosite is annotated with detailed, residue-level structural and biophysical information using state-of-the-art prediction tools. The platform is available at: https://iomics.ugent.be/scop3p/index</p> <p>P07949 example</p> <p>Visit the entry page for the protein of interest on ScoP3P: https://iomics.ugent.be/scop3p/index?protein=P07949</p> <p> P07949 on ScoP3P </p> <p>REST API access</p> <p>There are several endpoints to fetch the data Scop3P through HTTP methods. The API is documented using Swagger at https://iomics.ugent.be/scop3p/swagger-ui/index.html.</p> <p>P07949 REST API example</p> <p>The modifications for P07949 can be found at https://iomics.ugent.be/scop3p/api/modifications?accession=P07949:</p> Show JSON response <pre><code>{\n    \"proteinName\": \"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]\",\n    \"entryName\": \"RET_HUMAN\",\n    \"accession\": \"P07949\",\n    \"url\": \"https://iomics.ugent.be/scop3p/index?protein=P07949\",\n    \"modifications\": [\n        {\n        \"residue\": \"THR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": null,\n        \"position\": 291,\n        \"source\": \"PRIDE\",\n        \"reference\": null,\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 1\n        },\n        {\n        \"residue\": \"TYR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": null,\n        \"position\": 606,\n        \"source\": \"PRIDE\",\n        \"reference\": null,\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 1\n        },\n        {\n        \"residue\": \"SER\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": \"Combined\",\n        \"position\": 696,\n        \"source\": \"UP, PRIDE\",\n        \"reference\": \"PubMed:19369195\",\n        \"functionalScore\": 0.6410382,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 1\n        },\n        {\n        \"residue\": \"SER\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": null,\n        \"position\": 699,\n        \"source\": \"PRIDE\",\n        \"reference\": null,\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 1\n        },\n        {\n        \"residue\": \"TYR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": \"Experimental\",\n        \"position\": 806,\n        \"source\": \"UP\",\n        \"reference\": \"PubMed:14711813\",\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 0\n        },\n        {\n        \"residue\": \"TYR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": \"Experimental\",\n        \"position\": 809,\n        \"source\": \"UP\",\n        \"reference\": \"PubMed:14711813\",\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 0\n        },\n        {\n        \"residue\": \"TYR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": \"Experimental\",\n        \"position\": 900,\n        \"source\": \"UP\",\n        \"reference\": \"PubMed:14711813,PubMed:16928683\",\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 0\n        },\n        {\n        \"residue\": \"TYR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": \"Experimental\",\n        \"position\": 905,\n        \"source\": \"UP\",\n        \"reference\": \"PubMed:20117004,PubMed:14711813,PubMed:16928683,PubMed:28846099,PubMed:16778204\",\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 0\n        },\n        {\n        \"residue\": \"TYR\",\n        \"name\": \"phosphorylation\",\n        \"evidence\": \"Experimental\",\n        \"position\": 981,\n        \"source\": \"UP\",\n        \"reference\": \"PubMed:14711813\",\n        \"functionalScore\": null,\n        \"uniprotId\": null,\n        \"accession\": null,\n        \"specificSinglyPhosphorylated\": 0\n        }\n    ]\n}\n</code></pre>"},{"location":"follow_up_training/#122-scop3ptm","title":"1.2.2 ScoP3PTM","text":"<p>ScoP3P is being extended into ScoP3PTM, a broader resource that covers multiple types of post-translational modifications. The platform has expanded from 36 to 539 projects, and the number of processed spectra has grown from 60.2 million to approximately 1 billion. In addition to phosphorylation, ScoP3PTM includes more than 117 different modification types.</p> <p>P07949 example</p> <p>Visit the summary page for the protein of interest on ScoP3PTM: https://iomics.ugent.be/scop3ptm/P07949/summary</p> <p> P07949 on ScoP3PTM </p>"},{"location":"follow_up_training/#123-about-compomics","title":"1.2.3. About CompOmics","text":"<p>The CompOmics group, headed by Prof. Dr. Lennart Martens, is part of the Department of Biomolecular Medicine of the Faculty of Medicine and Health Sciences of Ghent University, and the VIB-UGent Center for Medical Biotechnology of VIB, both in Ghent, Belgium.</p> <p>The group has its roots in Ghent, but has active members all over Europe, and specializes in the management, analysis and integration of high-throughput Omics data with an aim towards establishing solid data stores, processing methods and tools to enable downstream systems biology research.</p>"},{"location":"follow_up_training/#13-structural-visualisations","title":"1.3 Structural visualisations","text":"<p>Mol* (<code>/molstar/</code>) <sup>2</sup> is a widely used component for rendering and exploring three-dimensional macromolecular structures in the browser.</p> <p>In addition, the MolViewSpec <sup>3</sup> library (https://molstar.org/mol-view-spec/) allows users to describe molecular visual scenes using a simple, declarative language. These descriptions can then be loaded directly into the Mol* viewer, enabling reproducible and shareable structural visualizations.</p> <ol> <li> <p>Pathmanaban Ramasamy, Demet Turan, Natalia Tichshenko, Niels Hulstaert, Elien Vandermarliere, Wim Vranken, and Lennart Martens. Scop3p: a comprehensive resource of human phosphosites within their full context. Journal of proteome research, 19(8):3478\u20143486, August 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00306, doi:10.1021/acs.jproteome.0c00306.\u00a0\u21a9</p> </li> <li> <p>David Sehnal, Sebastian Bittrich, Mandar Deshpande, Radka Svobodov\u00e1, Karel Berka, V\u00e1clav Bazgier, Sameer Velankar, Stephen K Burley, Jaroslav Ko\u010da, and Alexander S Rose. Mol* viewer: modern web app for 3d visualization and analysis of large biomolecular structures. Nucleic Acids Research, 49(W1):W431\u2013W437, 05 2021. URL: https://doi.org/10.1093/nar/gkab314, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W431/38842088/gkab314.pdf, doi:10.1093/nar/gkab314.\u00a0\u21a9</p> </li> <li> <p>Adam Midlik, Sebastian Bittrich, Jennifer R Fleming, Sreenath Nair, Sameer Velankar, Stephen K Burley, Jasmine Y Young, Brinda Vallat, and David Sehnal. Molviewspec: a mol* extension for describing and sharing molecular visualizations. Nucleic Acids Research, 53(W1):W408\u2013W414, 05 2025. URL: https://doi.org/10.1093/nar/gkaf370, arXiv:https://academic.oup.com/nar/article-pdf/53/W1/W408/63067309/gkaf370.pdf, doi:10.1093/nar/gkaf370.\u00a0\u21a9</p> </li> </ol>"},{"location":"keywords/","title":"Keywords","text":"<p>Here\u2019s a list of used keywords:</p> <p>biophysical b2bTools protein function protein structure structural biology PTM Scop3P Scop3PTM proteomics</p> <ol> <li> <p>Daniele Raimondi, Gabriele Orlando, Rita Pancsa, Taushif Khan, and Wim F Vranken. Exploring the sequence-based prediction of folding initiation sites in proteins. Scientific reports, 7(1):8826, August 2017. URL: https://europepmc.org/articles/PMC5562875, doi:10.1038/s41598-017-08366-3.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Alexandra Silva, Sandra Macedo-Ribeiro, Daniele Raimondi, and Wim Vranken. Accurate prediction of protein beta-aggregation with generalized statistical potentials. Bioinformatics, 36(7):2076\u20132081, 12 2019. URL: https://doi.org/10.1093/bioinformatics/btz912, arXiv:https://academic.oup.com/bioinformatics/article-pdf/36/7/2076/50670159/bioinformatics_36_7_2076.pdf, doi:10.1093/bioinformatics/btz912.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Luciano Porto Kagami, and Wim F Vranken. Shiftcrypt: a web server to understand and biophysically align proteins through their nmr chemical shift values. Nucleic Acids Research, 48(W1):W36\u2013W40, 05 2020. URL: https://doi.org/10.1093/nar/gkaa391, arXiv:https://academic.oup.com/nar/article-pdf/48/W1/W36/33432832/gkaa391.pdf, doi:10.1093/nar/gkaa391.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Tabaro, Francesco Codic\u00e8, Yves Moreau, and Wim F Vranken. Computational identification of prion-like rna-binding proteins that form liquid phase-separated condensates. Bioinformatics, 35(22):4617\u20134623, 04 2019. URL: https://doi.org/10.1093/bioinformatics/btz274, arXiv:https://academic.oup.com/bioinformatics/article-pdf/35/22/4617/48978636/bioinformatics_35_22_4617.pdf, doi:10.1093/bioinformatics/btz274.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Codic\u00e8, Francesco Tabaro, and Wim Vranken. Prediction of disordered regions in proteins with recurrent neural networks and protein dynamics. Journal of Molecular Biology, 434(12):167579, 2022. URL: https://www.sciencedirect.com/science/article/pii/S0022283622001590, doi:https://doi.org/10.1016/j.jmb.2022.167579.\u00a0\u21a9</p> </li> <li> <p>Jose Gavalda-Garcia, Adri\u00e1n D\u00edaz, and Wim Vranken. Bio2byte tools deployment as a python package and galaxy tool to predict protein biophysical properties. Bioinformatics (Oxford, England), 40(9):btae543, September 2024. URL: https://europepmc.org/articles/PMC11873786, doi:10.1093/bioinformatics/btae543.\u00a0\u21a9</p> </li> <li> <p>Elisa Cilia, Rita Pancsa, Peter Tompa, Tom Lenaerts, and Wim F Vranken. From protein sequence to dynamics and disorder with dynamine. Nature communications, 4:2741, 2013. URL: https://doi.org/10.1038/ncomms3741, doi:10.1038/ncomms3741.\u00a0\u21a9</p> </li> <li> <p>Luciano Porto Kagami, Gabriele Orlando, Daniele Raimondi, Francois Ancien, Bhawna Dixit, Jose Gavald\u00e1-Garc\u00eda, Pathmanaban Ramasamy, Joel Roca-Mart\u00ednez, Konstantina Tzavella, and Wim Vranken. B2btools: online predictions for protein biophysical features and their conservation. Nucleic Acids Research, 49(W1):W52\u2013W59, 05 2021. URL: https://doi.org/10.1093/nar/gkab425, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W52/38842326/gkab425.pdf, doi:10.1093/nar/gkab425.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Demet Turan, Natalia Tichshenko, Niels Hulstaert, Elien Vandermarliere, Wim Vranken, and Lennart Martens. Scop3p: a comprehensive resource of human phosphosites within their full context. Journal of proteome research, 19(8):3478\u20143486, August 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00306, doi:10.1021/acs.jproteome.0c00306.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Jasper Zuallaert, Lennart Martens, and Wim F Vranken. Assessing the relation between protein phosphorylation, alphafold3 models, and conformational variability. Protein science : a publication of the Protein Society, 35(1):e70376, January 2026. URL: https://europepmc.org/articles/PMC12723721, doi:10.1002/pro.70376.\u00a0\u21a9</p> </li> <li> <p>David Sehnal, Sebastian Bittrich, Mandar Deshpande, Radka Svobodov\u00e1, Karel Berka, V\u00e1clav Bazgier, Sameer Velankar, Stephen K Burley, Jaroslav Ko\u010da, and Alexander S Rose. Mol* viewer: modern web app for 3d visualization and analysis of large biomolecular structures. Nucleic Acids Research, 49(W1):W431\u2013W437, 05 2021. URL: https://doi.org/10.1093/nar/gkab314, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W431/38842088/gkab314.pdf, doi:10.1093/nar/gkab314.\u00a0\u21a9</p> </li> <li> <p>Adam Midlik, Sebastian Bittrich, Jennifer R Fleming, Sreenath Nair, Sameer Velankar, Stephen K Burley, Jasmine Y Young, Brinda Vallat, and David Sehnal. Molviewspec: a mol* extension for describing and sharing molecular visualizations. Nucleic Acids Research, 53(W1):W408\u2013W414, 05 2025. URL: https://doi.org/10.1093/nar/gkaf370, arXiv:https://academic.oup.com/nar/article-pdf/53/W1/W408/63067309/gkaf370.pdf, doi:10.1093/nar/gkaf370.\u00a0\u21a9</p> </li> <li> <p>The UniProt Consortium. Uniprot: the universal protein knowledgebase in 2025. Nucleic Acids Research, 53(D1):D609\u2013D617, 11 2024. URL: https://doi.org/10.1093/nar/gkae1010, arXiv:https://academic.oup.com/nar/article-pdf/53/D1/D609/60719276/gkae1010.pdf, doi:10.1093/nar/gkae1010.\u00a0\u21a9</p> </li> <li> <p>Geert van Geest, Elin Kronander, Jose Alejandro Romero Herrera, Nadja \u017dlender, ELIXIR Training Coordination Team, and Alexia Cardona. The elixir training lesson template - developing training together. May 2023. URL: https://doi.org/10.5281/zenodo.7913092, doi:10.5281/zenodo.7913092.mkdocs\u00a0\u21a9</p> </li> </ol>"},{"location":"chapters/chapter_01/","title":"1. Introducing this course","text":"<p>Welcome to this VIB training. The authors of this course designed a full teaching day that combines theory with hands-on activities, allowing participants to apply the concepts in practice.</p> <p>Section questions</p> <ol> <li>Why do we need this training ?</li> </ol>"},{"location":"chapters/chapter_01/#we-have-the-structures-now-what-next","title":"We have the structures now \u2014 what Next?","text":""},{"location":"chapters/chapter_01/#where-should-we-focus-to-understand-protein-behavior","title":"Where should we focus to understand protein behavior?","text":"<p>Proteins are often presented as static 3D structures, but in reality they are dynamic, context-dependent systems. Function does not emerge from a single snapshot\u2014it arises from conformational landscapes, biophysical properties, and regulatory modifications that change across conditions, cell types, and time.</p> <p>Post-translational modifications, such as phosphorylation, can reweight conformational states, alter interaction interfaces, and rewire signaling pathways without changing the underlying sequence. Likewise, mutations\u2014whether disease-causing or benign\u2014do not act uniformly: their impact depends on structural context, local dynamics, intrinsic disorder, and network connectivity within the protein.</p> <p>This training bridges the gap between sequence, structure, and function by moving beyond static models to:</p> <ul> <li>interpret backbone dynamics, intrinsic disorder, and folding propensities</li> <li>place PTMs and mutations in their structural and biophysical context</li> <li>understand how proteins sample multiple functional states, rather than a single \u201cnative\u201d structure</li> </ul> <p>By integrating structural models, biophysical annotations, and experimental proteomics evidence, we gain a mechanistic view of protein function, one that is essential for interpreting signaling, disease mutations, and regulatory complexity in real biological systems.</p>"},{"location":"chapters/chapter_01/#11-introducing-the-training-methodology","title":"1.1 Introducing the training methodology","text":"<p>The protein of interest for this training is the human proto-oncogene tyrosine-protein kinase receptor RET, encoded by the RET gene.  This protein is a receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation. It exits is multiple conformational states (phospho and non-phospho). You will learn more about it\u2019s biological context in Chapter 2.</p> <ol> <li>We will predict biophysical features for this protein using the Bio2Byte online platform, specifically the B2BTools suite. To enable a deeper analysis of these biophysical properties, we will generate a multiple sequence alignment (MSA) of sequences sharing at least 90% identity. This alignment will be used to identify conserved and variable patterns across homologous sequences.</li> <li>The MSA will be created using Clustal Omega, and the aligned kinase domain will be extracted using a Google Colab notebook.</li> <li>Post-translational modifications (PTMs) for the protein of interest will be explored using the Scop3P online platform, which is directly linked from the B2BTools prediction results. After analyzing the available information on modifications, structures, and experimental evidence, we will follow a more detailed protocol to link biophysical patterns with PTMs.</li> <li>Finally, the course will address the impact of mutations. We will show how to modify the wild-type sequence and assess the effect of single amino acid substitutions on biophysical profiles and predicted protein structures using AlphaFold v3.</li> </ol> <p>Training material: Jupyter notebooks</p> <p>Use the following link to launch the JupyterLab environment for this training:</p> <p></p> <p>The environment may take a few minutes to build and start. Please open the link now so that it is ready when needed later in the training.</p> User-interface example <p>This is how the interface will look like:</p> <p> JupyterLab interface. </p>"},{"location":"chapters/chapter_01/#12-elixir-belgium-node-services-used-in-this-training","title":"1.2 ELIXIR Belgium node services used in this training","text":"<p>Belgium is part of the ELIXIR Europe network as a National Node. The Belgian node, ELIXIR Belgium, provides both federal-level services and local initiatives, including research infrastructure, domain-specific services, training activities, and workshops.</p> ELIXIR Belgium <p>This course focuses on two bioinformatics tools and resources: B2BTools, used to predict and analyse protein biophysical features, and Scop3P, used to explore post-translational modifications (PTMs).</p>"},{"location":"chapters/chapter_01/#121-introduction-to-bio2byte-tools","title":"1.2.1 Introduction to Bio2Byte Tools","text":"<p>DynaMine <sup>1</sup> is a predictor specifically designed to estimate protein backbone dynamics. Backbone dynamics are related to, but not the same as, protein disorder. DynaMine was trained using values derived from NMR chemical shift data and therefore captures protein movements in solution. Its training set includes both fully folded proteins and intrinsically disordered proteins.</p> <p>The B2BTools tool suite <sup>2</sup> extends the original DynaMine predictor by including several predictors developed by the Bio2Byte lab.</p> <p>In addition to backbone dynamics, it provides predictions for side-chain dynamics and conformational preferences (alpha helix, beta sheet, and coil), all derived from NMR data and trained using the same methodology. The platform also includes predictors for early folding regions (EFoldMine) <sup>3</sup>, beta-sheet aggregation (AgMata) <sup>4</sup>, and protein disorder (DisoMine) <sup>5</sup>.</p>"},{"location":"chapters/chapter_01/#122-introduction-to-scop3p-and-scop3ptm","title":"1.2.2 Introduction to Scop3P (and Scop3PTM)","text":"<p>Scop3P <sup>6</sup>, developed at Ghent University and available online since June 2019, is a dedicated resource to explore and interpret the impact of phosphorylation sites on human protein structure and function. It supports researchers in analysing individual phosphosites or phosphoproteins within a structural, biophysical, and biological context.</p> <p>The resource integrates public data from several major international databases, including UniProtKB and the Protein Data Bank (PDB). In addition, it incorporates reprocessed mass spectrometry-based phosphoproteomics data from PRIDE/ProteomeXchange. These datasets are collected worldwide, making Scop3P a strongly international and community-driven resource.</p> <p>About the future of Scop3P and the development of Scop3PTM</p> <p>Scop3P is being extended to Scop3PTM</p> <ul> <li>Scop3PTM integrates information from di\ufb00erent knowledge bases and shows how re-analysis of large scale public proteomics data sets can add an additional level of significance and confidence to the PTM-sites.</li> <li>Scop3PTM system will provide a unique and powerful resource to understand the impact of PTM-sites on human protein structure-function relationship.</li> </ul> <p>Beta access is available at https://iomics.ugent.be/scop3ptm/.</p> <p>Let\u2019s get started: Go to chapter 2</p> <p>Next chapter explains the biological context.</p>"},{"location":"chapters/chapter_01/#13-rethinking-the-protein-structure-and-function","title":"1.3 Rethinking the protein structure and function","text":"<p>From \u201cAssessing the relation between protein phosphorylation, alphafold3 models, and conformational variability\u201d <sup>7</sup>:</p> <p>Proteins perform diverse functions critical to cellular processes. Transitions between functional states are often regulated by post-translational modifications (PTMs) such as phosphorylation, which dynamically influence protein structure, function, folding, and interactions. Dysregulation of PTMs can therefore contribute to diseases such as cancer and Alzheimer\u2019s. However, the structure\u2013function relationship between proteins and their modifications remains poorly understood due to a lack of experimental structural data, the inherent diversity of PTMs, and the dynamic nature of proteins. </p> <p>Recent advances in deep learning, particularly AlphaFold, have transformed protein structure prediction with near-experimental accuracy. However, it remains unclear whether these models can effectively capture PTM-driven conformational changes, such as those induced by phosphorylation. Here, we systematically evaluated AlphaFold models (AF2, AF3-non phospho, and AF3-phospho) to assess their ability to predict phosphorylation-induced structural diversity. By analyzing experimentally derived conformational ensembles, we found that all models predominantly aligned with dominant structural states, often failing to capture phosphorylation-specific conformations. Despite its phosphorylation-aware design, AF3-phospho predictions provided only modest improvement over AF2 and AF3-non phospho predictions. </p> <p>Our findings highlight key challenges in modeling PTM-driven structural landscapes and underscore the need for more adaptable structure prediction frameworks capable of capturing modification-induced conformational variability.</p>"},{"location":"chapters/chapter_01/#131-proteins-are-dynamic-systems-not-static-objects","title":"1.3.1 Proteins are dynamic systems, not static objects","text":""},{"location":"chapters/chapter_01/#132-limitations-of-deep-learningbased-structure-prediction","title":"1.3.2 Limitations of deep learning\u2013based structure prediction","text":""},{"location":"chapters/chapter_01/#133-memorization-and-dominant-conformations","title":"1.3.3 Memorization and dominant conformations","text":"<ol> <li> <p>Elisa Cilia, Rita Pancsa, Peter Tompa, Tom Lenaerts, and Wim F Vranken. From protein sequence to dynamics and disorder with dynamine. Nature communications, 4:2741, 2013. URL: https://doi.org/10.1038/ncomms3741, doi:10.1038/ncomms3741.\u00a0\u21a9</p> </li> <li> <p>Jose Gavalda-Garcia, Adri\u00e1n D\u00edaz, and Wim Vranken. Bio2byte tools deployment as a python package and galaxy tool to predict protein biophysical properties. Bioinformatics (Oxford, England), 40(9):btae543, September 2024. URL: https://europepmc.org/articles/PMC11873786, doi:10.1093/bioinformatics/btae543.\u00a0\u21a9</p> </li> <li> <p>Daniele Raimondi, Gabriele Orlando, Rita Pancsa, Taushif Khan, and Wim F Vranken. Exploring the sequence-based prediction of folding initiation sites in proteins. Scientific reports, 7(1):8826, August 2017. URL: https://europepmc.org/articles/PMC5562875, doi:10.1038/s41598-017-08366-3.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Alexandra Silva, Sandra Macedo-Ribeiro, Daniele Raimondi, and Wim Vranken. Accurate prediction of protein beta-aggregation with generalized statistical potentials. Bioinformatics, 36(7):2076\u20132081, 12 2019. URL: https://doi.org/10.1093/bioinformatics/btz912, arXiv:https://academic.oup.com/bioinformatics/article-pdf/36/7/2076/50670159/bioinformatics_36_7_2076.pdf, doi:10.1093/bioinformatics/btz912.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Codic\u00e8, Francesco Tabaro, and Wim Vranken. Prediction of disordered regions in proteins with recurrent neural networks and protein dynamics. Journal of Molecular Biology, 434(12):167579, 2022. URL: https://www.sciencedirect.com/science/article/pii/S0022283622001590, doi:https://doi.org/10.1016/j.jmb.2022.167579.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Demet Turan, Natalia Tichshenko, Niels Hulstaert, Elien Vandermarliere, Wim Vranken, and Lennart Martens. Scop3p: a comprehensive resource of human phosphosites within their full context. Journal of proteome research, 19(8):3478\u20143486, August 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00306, doi:10.1021/acs.jproteome.0c00306.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Jasper Zuallaert, Lennart Martens, and Wim F Vranken. Assessing the relation between protein phosphorylation, alphafold3 models, and conformational variability. Protein science : a publication of the Protein Society, 35(1):e70376, January 2026. URL: https://europepmc.org/articles/PMC12723721, doi:10.1002/pro.70376.\u00a0\u21a9</p> </li> </ol>"},{"location":"chapters/chapter_02/","title":"2. Introducing the biological context","text":"<p>Chapter questions</p> <ol> <li>How can protein biophysical properties help us understand function beyond what is visible from a static structure?</li> <li>Which regions of a signaling protein, such as a receptor tyrosine kinase, are most likely to be functionally regulated by dynamics or disorder?</li> <li>How can sequence conservation and divergence across species inform us about essential versus adaptable protein regions?</li> <li>Why might post-translational modifications preferentially occur in specific biophysical or structural contexts?</li> <li>How can mutations alter protein behaviour without strongly affecting the overall folded structure?</li> <li>What are the limitations of studying proteins using a single reference sequence or a single predicted structure?</li> </ol>"},{"location":"chapters/chapter_02/#21-the-target-protein-p07949","title":"2.1 The target protein P07949","text":"<p>This course is focused on the \u201cProto-oncogene tyrosine-protein kinase receptor Ret\u201d protein associated to the gene \u201cRET\u201d of homo sapiens. </p> <p>Subcellular location</p> <p>Based on the information extracted from UniProt, this protein can be found in:</p> <ol> <li>The cell membrane, the selectively permeable membrane which separates the cytoplasm from its surroundings: Single-pass type I membrane protein</li> <li>The membrane surrounding the endosome: Single-pass type I membrane protein</li> </ol> <p>Note: Predominantly located on the plasma membrane (PubMed:23333276, PubMed:9575150). In the presence of SORL1 and GFRA1, directed to endosomes (PubMed:23333276).</p> <p>This protein has a sequence length of 1114 amino acids. It can be found in UniProtKB <sup>1</sup> under the accession number P07949 or the entry name RET_HUMAN.</p> <p>Protein sequence</p> <p>Although the UniProt entry describes two isoforms, produced by alternative splicing, this course is based on the canonical sequence in FASTA format: P07949-1 (P07949 \u00b7 RET_HUMAN).</p> View sequence <pre><code>&gt;sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3\nMAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAP\nEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLT\nVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR\nPPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELV\nAVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFD\nADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR\nNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFA\nQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAE\nLHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR\nCEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPR\nGIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCY\nHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP\nRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK\nQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH\nPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY\nEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL\nFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAA\nSTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRA\nDGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS\n</code></pre> <p>Crystal structure 2IVS</p> <p>Representation of the crystal structure using Mol*:</p> View 2IVS <p></p> <p>2IVS: Crystal structure of non-phosphorylated ret tyrosine kinase domain (Protein Data Bank in Europe Knowledge Base)</p> <p>According to the functional annotation provided by UniProt, this protein plays a central role in several cellular processes:</p> <ul> <li>This protein is a receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation in response to glia cell line-derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15). In contrast to most receptor tyrosine kinases, RET requires not only its cognate ligands but also coreceptors, for activation. </li> <li>It acts as a dependence receptor via the GDNF-GFRA1 signaling: in the presence of the ligand GDNF in somatotrophs within pituitary, promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF.</li> <li>It is required for the molecular mechanisms orchestration during intestine organogenesis via the ARTN-GFRA3 signaling: involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer\u2019s patch-like structures, a major component of the gut-associated lymphoid tissue (By similarity).</li> <li>It mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which triggers an aversive response, characterized by nausea, vomiting, and/or loss of appetite in response to various stresses.</li> <li>It modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner.</li> <li>Also, it is active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage.</li> <li>It triggers the differentiation of rapidly adapting (RA) mechanoreceptors.</li> <li>It phosphorylates PTK2/FAK1.</li> </ul> <p>Crystal structure 6NJA</p> View 6NJA <p>Representation of the crystal structure using Mol*:</p> <p></p> <p>6NJA: Crystal structure of phosphorylated ret tyrosine kinase domain (Protein Data Bank in Europe Knowledge Base)</p>"},{"location":"chapters/chapter_02/#22-the-target-kinase-domain","title":"2.2 The target Kinase domain","text":"<p>In this training, we will focus on a specific protein domain: the kinase domain, located approximately between positions 724 and 1016 of the protein sequence.</p> <p>Protein Kinase domain sequence: range 724 to 1016</p> <p>Here you can find the domain sequence in FASTA format (PROSITE-ProRule: PRU00159).</p> View sequence <pre><code>LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV\nNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP\nDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY\nEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER\nLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYL\n</code></pre> View predicted model AF-P07949-F1-v6 <p></p> <p>The predicted model <code>AF-P07949-F1-v6</code> by AlphaFold Protein Structure Database.</p>"},{"location":"chapters/chapter_02/#23-structural-overview","title":"2.3 Structural overview","text":"<p>MolViewStories is a powerful web application that lets you create beautiful, interactive molecular visualizations. Whether you\u2019re a researcher, educator, or student, MolViewStories helps you tell compelling scientific stories using 3D molecular structures.</p> <p>This story shows the different structures related to RET protein (P07949) focusing on the kinase domain:</p> <p>To be continued: Go to chapter 3</p> <p>Next chapter explains how to predict biological profiles.</p> <ol> <li> <p>The UniProt Consortium. Uniprot: the universal protein knowledgebase in 2025. Nucleic Acids Research, 53(D1):D609\u2013D617, 11 2024. URL: https://doi.org/10.1093/nar/gkae1010, arXiv:https://academic.oup.com/nar/article-pdf/53/D1/D609/60719276/gkae1010.pdf, doi:10.1093/nar/gkae1010.\u00a0\u21a9</p> </li> </ol>"},{"location":"chapters/chapter_03/","title":"3. Building biological profiles","text":"<p>This chapter moves from theory to practice by predicting the \u201canatomy\u201d of the protein at the level of its biophysical properties. Using the B2BTools suite, we will explore how different regions of the protein behave in terms of dynamics, structure, and flexibility.</p> <p>Chapter questions</p> <ol> <li>How to use the B2BTools online platform to predict biophysical profiles for protein sequences ?</li> <li>How to find biophysical patterns using the platform ? </li> </ol>"},{"location":"chapters/chapter_03/#31-biophysical-profiles","title":"3.1 Biophysical profiles","text":"<p>This package <sup>1</sup> offers biophysical feature predictors for protein sequences as well as different file parses and other utilities to help you with your protein data analysis. If your input data consists on one or more sequences not aligned, we provide you with the Single Sequence mode. On the other hand, if your input is a Multiple Sequence Alignment (MSA), we provide the MSA mode. For NMR data, we have the predictor ShiftCrypt (out of the scope of this course).</p> Predictor Description Publication <code>DynaMine</code> <sup>2</sup> Fast predictor of protein backbone dynamics using only sequence information as input. The version here also predicts side-chain dynamics and secondary structure predictors using the same principle. doi: 10.1038/ncomms3741 <code>DisoMine</code> <sup>3</sup> Predicts protein disorder with recurrent neural networks not directly from the amino acid sequence, but instead from more generic predictions of key biophysical properties, here protein dynamics, secondary structure and early folding. doi: 10.1016/j.jmb.2022.167579 <code>EFoldMine</code> <sup>4</sup> Predicts from the primary amino acid sequence of a protein, which amino acids are likely involved in early folding events. doi: 10.1038/s41598-017-08366-3 <code>AgMata</code> <sup>5</sup> Single-sequence based predictor of protein regions that are likely to cause beta-aggregation. doi: 10.1093/bioinformatics/btz912 <code>PSPer</code> <sup>6</sup> PSP (Phase Separating Protein) predicts whether a protein is likely to phase-separate with a particular mechanism involving RNA interacts (FUS-like proteins). It will highlight the regions in your protein that are involved mechanistically, and provide an overall score. doi: 10.1093/bioinformatics/btz274 <code>Shift Crypt</code> <sup>7</sup> Auto-encoding NMR chemical shifts from their native vector space to a residue-level biophysical index doi: 10.1093/nar/gkaa391"},{"location":"chapters/chapter_03/#311-dynamine","title":"3.1.1 DynaMine","text":"<p>DynaMine predicts local protein backbone dynamics directly from the amino acid sequence. More specifically, it estimates how rigid or flexible each residue is expected to be in solution, based on fast (nanosecond-scale) backbone motions.</p> <p>The predictor was trained on backbone order parameters derived from NMR chemical shift data, which reflect protein behaviour in solution rather than a single static structure. Because of this, DynaMine captures intrinsic conformational tendencies that are independent of a specific folded state.</p> <p>The output is a per-residue numerical score:</p> <ul> <li>Higher values indicate rigid regions with a strong tendency to adopt stable conformations</li> <li>Lower values indicate flexible or dynamic regions</li> </ul> <p>Backbone dynamics are not equivalent to intrinsic disorder. A residue may be flexible while still being part of a folded structure, and rigid residues are not guaranteed to be structured under all conditions. DynaMine scores should therefore be interpreted as biophysical propensities, not as absolute structural assignments.</p> <p>Specifically, for the backbone propensity prediction, the range values are:</p> <ul> <li>Values &gt; 1.0: Membrane spanning regions</li> <li>Values &gt; 0.80 and &lt; 1.0: Rigid conformations</li> <li>Values &gt; 0.69 and &lt; 0.80: Context dependent</li> <li>Values &lt; 0.69: Flexible regions</li> </ul> <p>Backbone plot example</p> <p> DynaMine backbone dynamics for P08100 </p>"},{"location":"chapters/chapter_03/#312-disomine","title":"3.1.2 DisoMine","text":"<p>DisoMine predicts intrinsic disorder, defined as regions of a protein that do not adopt a stable three-dimensional structure under physiological conditions.</p> <p>The model was trained on experimentally annotated disordered regions from curated datasets and predicts disorder at the residue level. Unlike many disorder predictors, DisoMine does not rely directly on amino acid composition or evolutionary profiles. Instead, it uses predicted biophysical properties\u2014such as backbone dynamics, secondary structure propensity, and early folding behaviour\u2014as input.</p> <p>The output is a probability score between 0 and 1:</p> <ul> <li>Higher values indicate a higher likelihood that the residue is intrinsically disordered</li> <li>Lower values indicate a tendency toward structured behaviour</li> </ul> <p>DisoMine is particularly effective at identifying long disordered regions. The predictions are probabilistic and context-dependent: a high disorder score does not imply permanent disorder in all conditions, but rather a strong tendency to remain flexible or unstructured.</p> <p>The threshold for this prediction is:</p> <ul> <li>Above 0.5: likely a disordered position</li> <li>Below: unlikely a disordered position</li> </ul> <p>Disorder plot example</p> <p> DisoMine disorder propensities for P08100 </p>"},{"location":"chapters/chapter_03/#313-efoldmine","title":"3.1.3 EFoldMine","text":"<p>EFoldMine predicts early folding residues, defined as amino acids that are likely to form stable local structure at the very beginning of the protein folding process.</p> <p>The predictor was trained using experimental data derived from hydrogen\u2013deuterium exchange experiments, which identify residues that gain protection early during folding. EFoldMine therefore focuses on folding kinetics, rather than final structure.</p> <p>The output highlights residues with high early folding propensity:</p> <ul> <li>These residues are likely to initiate local structure formation</li> <li>They may play a key role in guiding the folding pathway</li> </ul> <p>Early folding residues are not necessarily rigid, conserved, or part of the final folded core. EFoldMine does not predict folding rates or final stability, but rather identifies sequence-encoded folding initiation signals that act early in the folding process.</p> <p>The threshold for this prediction is:</p> <ul> <li>Values &gt; 0.169: indicate residues that are likely to start the protein folding process</li> <li>Below: indicate residues that are unlikely to start the protein folding process</li> </ul> <p>EFoldMine plot example</p> <p> EFoldMine early folding events for P08100 </p>"},{"location":"chapters/chapter_03/#314-agmata","title":"3.1.4 AgMata","text":"<p>AgMata predicts beta-sheet aggregation propensity from single protein sequences. It identifies regions that are intrinsically prone to form intermolecular beta-sheet interactions, a key feature of amyloid-like aggregation.</p> <p>Unlike many aggregation predictors, AgMata is not directly trained on known aggregating sequences. Instead, it uses a generalized statistical potential that integrates predicted biophysical properties, including backbone dynamics and secondary structure tendencies.</p> <p>The output highlights regions with increased aggregation risk:</p> <ul> <li>Higher values indicate a stronger intrinsic tendency toward beta-aggregation</li> <li>Lower values indicate reduced aggregation propensity</li> <li>Peaks indicate residues likely to be involved in beta-sheet aggregation.</li> </ul> <p>AgMata predictions reflect intrinsic sequence-level risk, not actual aggregation outcomes. Cellular context, protein concentration, interaction partners, and chaperones are not considered. The predictor is most informative when interpreted together with disorder and dynamics predictions.</p> <p>AgMata plot example</p> <p> AgMata beta-aggregation for P08100 </p> <p>AgMata takes longer to predict the peaks</p> <p>Some of the activities will skip this predictor due to long waiting times.</p>"},{"location":"chapters/chapter_03/#32-extracting-the-protein-sequence","title":"3.2 Extracting the protein sequence","text":"<p>The first step is to download the protein sequence in FASTA format.</p> <p>Hands-on: P07949 canonical sequence</p> <ol> <li>Download the canonical protein sequence from UniProtKB. </li> <li>Visit the official UniProtKB website, locate the protein entry.</li> <li>Download the FASTA sequence from the contextual menu.</li> </ol> Solution <p>The following FASTA sequence corresponds to the protein of interest and was retrieved from https://rest.uniprot.org/uniprotkb/P07949.fasta:</p> <pre><code>&gt;sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3\nMAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAP\nEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLT\n...\nDGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS\n</code></pre> <p> You should now have the file <code>P07949.fasta</code> available in your working environment.</p> <pre><code>./training-data-directory\n\u2514\u2500\u2500\u2500 P07949.fasta\n</code></pre>"},{"location":"chapters/chapter_03/#33-analysing-single-sequences-standalone-mode","title":"3.3 Analysing single sequences (standalone mode)","text":"<p>As mentioned earlier, the B2BTools suite provides several predictors to analyse protein biophysical properties:</p> <ul> <li>Backbone and side-chain dynamics (via DynaMine)</li> <li>Intrinsically disordered residues (via DisoMine)</li> <li>Early folding regions (via EFoldMine)</li> <li>Beta-aggregation-prone regions (via AgMata)</li> </ul> <p>The Bio2Byte lab provides an online platform <sup>8</sup> to run the biophysical predictions described above for proteins of interest. The platform is available at: https://bio2byte.be/online_predictors/ (this resource is still under active development, and user feedback is highly appreciated. A previous version of the platform is available at: https://bio2byte.be/b2btools).</p> <p>Attention: Required token</p> <p>First of all, write down in your notes a personal alphanumeric TOKEN to enable job submission and later retrieval of results on the B2BTools platform.</p> <ol> <li>Access the B2BTools platform and set your token.</li> <li>The token will be saved in your browser internal storage and remembered every time you access again the website.</li> </ol> Where is the TOKEN textbox? <p> Notice the input textbox for your TOKEN </p> <p>Hands-on: Predicting the biophysical features</p> <ol> <li>Select the Single Sequence analysis type and upload your FASTA file.  </li> <li>Submitted jobs can be accessed from the Token results page: https://bio2byte.be/online_predictors/past-results/.</li> <li>Locate your job and open the corresponding results page.</li> </ol> Solution <ol> <li>You will be able to find the results inside the \u201cSingle Sequence Predictions\u201d table. </li> <li>Your job will have an action button \u201cView Results\u201d that opens a link like <code>https://bio2byte.be/online_predictors/results/UUID/</code>.</li> </ol>"},{"location":"chapters/chapter_03/#331-understanding-the-results-as-biological-profiles","title":"3.3.1 Understanding the results as biological profiles","text":""},{"location":"chapters/chapter_03/#3311-visualization-of-biophysical-profiles","title":"3.3.1.1 Visualization of biophysical profiles","text":"Explore the overview predictions <p> Plot for prediction values: x-axis represents the sequence positions and y-axis contains the values predicted by this tool. </p>"},{"location":"chapters/chapter_03/#3312-exploring-intrinsic-flexibility-and-folding-propensity","title":"3.3.1.2 Exploring intrinsic flexibility and folding propensity","text":"Explore dynamics <p> Plot for prediction values: x-axis represents the sequence positions and y-axis contains the values predicted by this tool. </p> Explore Early folding events <p> Plot for prediction values: x-axis represents the sequence positions and y-axis contains the values predicted by this tool. </p> Explore Disorder <p> Plot for prediction values: x-axis represents the sequence positions and y-axis contains the values predicted by this tool. </p> Explore Beta-Aggregation propensities <p> Plot for prediction values: x-axis represents the sequence positions and y-axis contains the values predicted by this tool. </p> <p>Interactive results</p> <p>For further details: Open the results on the B2BTools platform.</p> <p>\u2615\ufe0f COFFEE BREAK</p> <p>Time to grab a coffee or tea. We\u2019ll be back in ten minutes\u2026</p>"},{"location":"chapters/chapter_03/#34-multiple-sequence-alignments-msa","title":"3.4 Multiple sequence alignments (MSA)","text":"<p>To fully exploit the predictive power of biophysical tools, it is useful to study the target protein in the context of related proteins. Comparing similar sequences allows the identification of conserved biophysical profiles as well as positions that show divergence across homologs.</p>"},{"location":"chapters/chapter_03/#341-working-with-the-aligned-kinase-domain","title":"3.4.1 Working with the aligned kinase domain","text":"<p>In the following hands-on activities the focus will be on the homolog kinase domains of the P07949\u2019s 90%-similarity proteins. </p>"},{"location":"chapters/chapter_03/#3411-fetching-the-similar-proteins","title":"3.4.1.1 Fetching the similar proteins","text":"<p>UniProtKB provides access to similar proteins directly from the protein entry page, in the Similar proteins section.</p> <p>Hands-on: Getting the 90%-identity protein sequences</p> <p>Open the protein entry in UniProtKB and locate the Similar proteins table at: https://www.uniprot.org/uniprotkb/P07949/entry#similar_proteins.</p> <p>Select the entries with 90% sequence identity and choose to view all results in UniProtKB.</p> <p>Exclude other human proteins and short sequences to retain proteins with lengths between 1000 and 1120 amino acids. Once the entries are selected, download the canonical sequences using the Download option in FASTA format, without compression.</p> <p>Before proceeding with the alignment, add the <code>P07949</code> sequence at the top of the downloaded FASTA file.</p> Solution <p>The canonical sequences can be retrieved from the following UniProtKB REST endpoint.</p> <p>The FASTA file contains all the sequences: </p> <pre><code>&gt;tr|A0A0D9REZ9|A0A0D9REZ9_CHLSB Proto-oncogene tyrosine-protein kinase receptor Ret OS=Chlorocebus sabaeus OX=60711 GN=RET PE=3 SV=1\nLTSLLPTVALGLYFSRDAYWEKLYVDQPAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYR\nTRLHENNWICIQEDTGLLYLNRSLDRSSWEKLSGRNRGFPLLTVYLKVFLSPTFLREGEC\n...\nYANWMLSPSAAKLMDTFDS\n\n&gt;tr|A0A2K5MKU6|A0A2K5MKU6_CERAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Cercocebus atys OX=9531 GN=RET PE=3 SV=1\nMAKATSGAAGLRLLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQPAGTPLLYVHALRDS\nPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSGRNRGFPLL\n...\nADGTNTGFPRYANDSVYANWMLSPSAAKLMDTFDS\n...\n\n&gt;tr|H9ZC00|H9ZC00_MACMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca mulatta OX=9544 GN=RET PE=2 SV=1\nMAKATSGAAGLRLLLLLLLLPLLGKGALGLYFSRDAYWEKLYVDQPAGTPLLYVHALRDA\nPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDRSSWEKLSGRNRGFPLL\n...\nASTPSDSLLYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGRISHAFTRF\n</code></pre> <p> You should now have the file <code>P07949.90-similar.fasta</code> available in your working environment.</p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta\n\u2514\u2500\u2500\u2500 P07949.90-similar.fasta\n</code></pre>"},{"location":"chapters/chapter_03/#3412-building-the-msa","title":"3.4.1.2 Building the MSA","text":"<p>To continue this activity, the multiple sequence alignment (MSA) will be generated using the online Clustal Omega server provided by EMBL-EBI.</p> <p>Hands-on: Aligning the sequences</p> <ol> <li>Open the Clustal Omega submission form at: https://www.ebi.ac.uk/jdispatcher/msa/clustalo.</li> <li>Upload the file <code>P07949.90-similar.fasta</code> as input.  </li> <li>Request the output format as Pearson/FASTA and keep the original sequence order by setting the order option to input.</li> <li>Set the job title to <code>P07949.90-similar.msa</code>.</li> </ol> Solution <p>After the job has completed on the EMBL-EBI servers, you will be redirected to the results page. This page contains several tabs for exploring the alignment.</p> <p>From the Tool output tab, download the MSA by clicking the blue Download button.</p> <p>Example of the aligned P07949 protein sequence:</p> <pre><code>&gt;sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3\nMAKATSGAAGLRLLLL--LLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRD\n...\nLKQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS\n...\nLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS\n</code></pre> <p> You should now have the file <code>P07949.90-similar.msa.fasta</code> available in your working environment.</p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.fasta\n\u2514\u2500\u2500\u2500 P07949.90-similar.msa.fasta\n</code></pre>"},{"location":"chapters/chapter_03/#3413-extracting-the-domain-of-interest","title":"3.4.1.3 Extracting the domain of interest","text":"<p>The next step is to focus the analysis on the kinase domain positions across all aligned sequences. For this purpose, the course provides a Google Colab notebook that runs a Python script to identify and extract the aligned positions corresponding to a defined amino acid range in the original reference sequence.</p> <p>Attention: Google Account required</p> <p>You must log in using a Google account to run the code in this notebook. By default, you can use your \u201c@gmail.com\u201d address.</p> <p>Hands-on: Extracting the aligned domain from the MSA</p> <ol> <li>Open the Google Colab notebook related to this activity.</li> <li>The notebook is divided into two main sections.  </li> <li>First, run the four hidden cells in the section Dependencies and method definitions by clicking the Run icon. This step loads the required Python libraries and helper functions into memory.</li> <li>Next, move to the Usage section and execute the cells in order.  </li> <li>The first cell will prompt you to upload the alignment file <code>P07949.90-similar.msa.fasta</code>.</li> <li>After the file is uploaded, fill in the fields in the Extraction parameters cell and click the Run icon to start the extraction.</li> <li>Once the execution is complete, download the output file from the Files panel to your local working environment.</li> </ol> Solution <ol> <li>Use the following parameters in the Extraction parameters cell, based on the kinase domain definition:<ul> <li><code>uniprot_id</code>: <code>P07949</code></li> <li><code>start_pos</code>: <code>724</code></li> <li><code>end_pos</code>: <code>1016</code></li> <li><code>max_gap_fraction</code>: <code>0.4</code> (40%)</li> <li><code>output_filename</code>: <code>P07949.90-similar.msa.kinase.fasta</code></li> </ul> </li> <li>Save the file from the Files panel on the left navigation (folder icon), locate the file, open the contextual menu, and select Download.</li> </ol> Output console message <p>After running the cell, a new file will be generated and a summary message similar to the one below will be displayed:</p> <pre><code>Parameters:\nUniProt ID: P07949\nStart Position: 724\nEnd Position: 1016\nMax Gap Fraction: 0.4\nFor sp|P07949|RET_HUMAN: found 0.006779661016949152 as gap fraction (seq len: 295)\nFor tr|A0A0D9REZ9|A0A0D9REZ9_CHLSB: found 0.0 as gap fraction (seq len: 295)\n...\nFile P07949.90-similar.msa.kinase.fasta written using alignment columns: 725 and 1020 (295 residues)\n</code></pre> Kinase sequences <p>The extracted alignment will start as follows:  </p><pre><code>&gt;sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3\nLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP\n...\nNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYL\n\n&gt;tr|A0A0D9REZ9|A0A0D9REZ9_CHLSB Proto-oncogene tyrosine-protein kinase receptor Ret OS=Chlorocebus sabaeus OX=60711 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQDAPGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP\n...\nNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n</code></pre> <p> You should now have the file <code>P07949.90-similar.msa.kinase.fasta</code> available in your working environment.</p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.fasta\n\u2514\u2500\u2500\u2500 P07949.90-similar.msa.kinase.fasta\n</code></pre>"},{"location":"chapters/chapter_03/#3414-predicting-the-aligned-biophysical-features","title":"3.4.1.4 Predicting the aligned biophysical features","text":"<p>We are now ready to predict the aligned biophysical features using B2BTools.</p> <p>Hands-on: Predicting the aligned biophysical features for the kinase domain</p> <ol> <li>Open a new browser tab and go to the online platform at: https://bio2byte.be/online_predictors</li> <li>This time, select Multiple Sequence Alignment as the analysis type instead of Single Sequence. Upload the file <code>P07949.90-similar.msa.kinase.fasta</code> and submit the job.</li> <li>After submission, you will be redirected to the Token results page.</li> </ol> Solution <ol> <li>Once the prediction job has completed, the results will appear in the MSA Predictions table. It takes approximately less than two minutes to finish.</li> <li>Click the View Results button to open the results page for the aligned kinase domain.</li> </ol>"},{"location":"chapters/chapter_03/#342-understanding-the-aligned-results-as-biological-profiles","title":"3.4.2 Understanding the aligned results as biological profiles","text":""},{"location":"chapters/chapter_03/#3421-exploring-intrinsic-flexibility-and-folding-propensity","title":"3.4.2.1 Exploring intrinsic flexibility and folding propensity","text":"Explore the overview values <p> Plot for prediction values: x-axis represents the sequence positions and y-axis contains the values predicted by this tool. </p> Explore the aligned values for P07949 <p> Aligned dynamics predictions for a single protein (including gaps). </p> <p> Aligned early folding events, disorder and beta-aggregation predictions for a single protein (including gaps). </p> Explore the values mapped to the 3D structure <p> Mapping 1D-3D over the predicted 3D structure by AlphaFold  </p>"},{"location":"chapters/chapter_03/#3422-visualization-of-biophysical-profiles","title":"3.4.2.2 Visualization of biophysical profiles","text":"Explore the 90%-identity aligned backbone dynamics <p>  Explore the aligned predictions in the context of sequence conservation . </p> Explore the 90%-identity aligned early folding events <p>  Explore the aligned predictions in the context of sequence conservation . </p> Explore the 90%-identity aligned disorder propensities <p>  Explore the aligned predictions in the context of sequence conservation . </p> Explore the 90%-identity aligned beta-aggregation propensities <p>  Explore the aligned predictions in the context of sequence conservation . </p> <p>In conclusion, as you see, working with 90%-identity sequences shows how well conserved are the biophysical profiles for this domain.</p> <p>Interactive results</p> <p>For further details: Open the results on the B2BTools platform.</p>"},{"location":"chapters/chapter_03/#35-analysing-the-50-identity-aligned-kinase-domains","title":"3.5 Analysing the 50% identity aligned kinase domains","text":"<p>Given the 90% of identity does not allow us to see variability in the biophysical profiles, this section introduces the results for the sequences with 50% of identity extracted from UniProt.</p> <p>Using the sequences as input for Clustal Omega to align the sequences, the next step is to extract the aligned domain via the Google Colab Notebook.</p> View the aligned kinase sequences <p>This is the alignment in FASTA format:</p> <pre><code>&gt;tr|A0A0D9REZ9|A0A0D9REZ9_CHLSB Proto-oncogene tyrosine-protein kinase receptor Ret OS=Chlorocebus sabaeus OX=60711 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQDAPGPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A1U7Q3L7|A0A1U7Q3L7_MESAU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Mesocricetus auratus OX=10036 GN=Ret PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPGYV---GGGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYHLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2K5MKU6|A0A2K5MKU6_CERAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Cercocebus atys OX=9531 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2K5V8L5|A0A2K5V8L5_MACFA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca fascicularis OX=9541 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2K6CCS4|A0A2K6CCS4_MACNE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca nemestrina OX=9545 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2R9B0Q5|A0A2R9B0Q5_PANPA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pan paniscus OX=9597 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2Y9LJM0|A0A2Y9LJM0_DELLE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Delphinapterus leucas OX=9749 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A452UNU5|A0A452UNU5_URSMA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Ursus maritimus OX=29073 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A4W2I9B2|A0A4W2I9B2_BOBOX Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos indicus x Bos taurus OX=30522 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A6I9MCH9|A0A6I9MCH9_PERMB Proto-oncogene tyrosine-protein kinase receptor Ret OS=Peromyscus maniculatus bairdii OX=230844 GN=Ret PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPGYV---GSGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A8B8VKU7|A0A8B8VKU7_BALMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Balaenoptera musculus OX=9771 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8C0AKK2|A0A8C0AKK2_BOSMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos mutus grunniens OX=30521 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGILLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8C0LH73|A0A8C0LH73_CANLU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Canis lupus dingo OX=286419 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8C0TSX7|A0A8C0TSX7_CANLF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Canis lupus familiaris OX=9615 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8C2MD48|A0A8C2MD48_CRIGR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Cricetulus griseus OX=10029 GN=Ret PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPGYV---GGGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A8C4LI87|A0A8C4LI87_EQUAS Proto-oncogene tyrosine-protein kinase receptor Ret OS=Equus asinus OX=9793 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A8C6C2Y9|A0A8C6C2Y9_MONMO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Monodon monoceros OX=40151 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8C7BT94|A0A8C7BT94_NEOVI Proto-oncogene tyrosine-protein kinase receptor Ret OS=Neovison vison OX=452646 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGDV---GSGGSRSSSYL\nDSPGERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8C8XS60|A0A8C8XS60_PANLE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Panthera leo OX=9689 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8C9C6W7|A0A8C9C6W7_PHOSS Proto-oncogene tyrosine-protein kinase receptor Ret OS=Phocoena sinus OX=42100 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8I3PW06|A0A8I3PW06_CANLF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Canis lupus familiaris OX=9615 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A9V1FDH5|A0A9V1FDH5_PANPR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Panthera pardus OX=9691 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|F1MS00|F1MS00_BOVIN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos taurus OX=9913 GN=RET PE=3 SV=3\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|F1RG22|F1RG22_PIG Proto-oncogene tyrosine-protein kinase receptor Ret OS=Sus scrofa OX=9823 GN=RET PE=3 SV=4\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRHSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|F6S299|F6S299_MACMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca mulatta OX=9544 GN=RET PE=3 SV=3\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|F6WV32|F6WV32_HORSE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Equus caballus OX=9796 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|G1MES8|G1MES8_AILME Proto-oncogene tyrosine-protein kinase receptor Ret OS=Ailuropoda melanoleuca OX=9646 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|G1S142|G1S142_NOMLE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Nomascus leucogenys OX=61853 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDDPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|G3QLZ3|G3QLZ3_GORGO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Gorilla gorilla gorilla OX=9595 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|G3TIZ2|G3TIZ2_LOXAF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Loxodonta africana OX=9785 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLHGACSQD--GPLFLIVEYAKYGSLRGFLRESRKVGPSYV---GSGGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|H2NA70|H2NA70_PONAB Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pongo abelii OX=9601 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|H2Q1T9|H2Q1T9_PANTR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pan troglodytes OX=9598 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|M3Z0Q6|M3Z0Q6_MUSPF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Mustela putorius furo OX=9669 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLHGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGDV---GSGGSRSSSYL\nDSPGERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3\nLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYL\n&gt;tr|A0A2I3LXM4|A0A2I3LXM4_PAPAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Papio anubis OX=9555 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2I3TR47|A0A2I3TR47_PANTR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pan troglodytes OX=9598 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2Y9HVS1|A0A2Y9HVS1_NEOSC Proto-oncogene tyrosine-protein kinase receptor Ret OS=Neomonachus schauinslandi OX=29088 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A452SFQ5|A0A452SFQ5_URSAM Proto-oncogene tyrosine-protein kinase receptor Ret OS=Ursus americanus OX=9643 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A455AMB7|A0A455AMB7_PHYMC Proto-oncogene tyrosine-protein kinase receptor Ret OS=Physeter macrocephalus OX=9755 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A4W2IB41|A0A4W2IB41_BOBOX Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos indicus x Bos taurus OX=30522 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A667GWR4|A0A667GWR4_LYNCA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Lynx canadensis OX=61383 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A667HC96|A0A667HC96_LYNCA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Lynx canadensis OX=61383 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A6J1ZQD7|A0A6J1ZQD7_ACIJB Proto-oncogene tyrosine-protein kinase receptor Ret OS=Acinonyx jubatus OX=32536 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A6J3Q7G4|A0A6J3Q7G4_TURTR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Tursiops truncatus OX=9739 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A6P5AYE8|A0A6P5AYE8_BOSIN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos indicus OX=9915 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A7N9CS34|A0A7N9CS34_MACFA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca fascicularis OX=9541 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A8B7TAT6|A0A8B7TAT6_HIPAR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Hipposideros armiger OX=186990 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPNELRDLLSEFNLLKQVN\nHPNVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKAGPGYV---GSRGSHGSSYL\nDNPDERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYL\n&gt;tr|A0A8B8U0M5|A0A8B8U0M5_CAMFR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Camelus ferus OX=419612 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASTSEMRDLQSEFNLLKQVN\nHPQVIKLYGACSQG--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGDSRSSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8B9YW94|A0A8B9YW94_BOSMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos mutus grunniens OX=30521 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIES-LDHIYTTQSDVWSFGILLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8C9JHD3|A0A8C9JHD3_PANTA Ret proto-onco OS=Panthera tigris altaica OX=74533 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GKAGQG------------------TGSCPVQAGGSGTSKAAACL\nGHPRRRLPG--TEIRA-----------------------------ARRPGH-----WPER\nAVSLCPLTGGGRGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8D2EQF8|A0A8D2EQF8_THEGE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Theropithecus gelada OX=9565 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A8U0NS18|A0A8U0NS18_MUSPF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Mustela putorius furo OX=9669 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLHGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGDV---GSGGSRSSSYL\nDSPGERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A9W2WDK0|A0A9W2WDK0_PHYMC Proto-oncogene tyrosine-protein kinase receptor Ret OS=Physeter macrocephalus OX=9755 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0AAV0A2E7|A0AAV0A2E7_PHORO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Phodopus roborovskii OX=109678 GN=Ret PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPGYV---GSGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|L8HXX9|L8HXX9_9CETA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos mutus OX=72004 GN=M91_06547 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGILLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A2I3H8C4|A0A2I3H8C4_NOMLE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Nomascus leucogenys OX=61853 GN=RET PE=3 SV=1\nE-------------------------KDRLQPALCCISENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDDPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2J8IX93|A0A2J8IX93_PANTR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pan troglodytes OX=9598 GN=CK820_G0052381 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A2R9AWY2|A0A2R9AWY2_PANPA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pan paniscus OX=9597 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0A3Q7R7R3|A0A3Q7R7R3_CALUR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Callorhinus ursinus OX=34884 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A4U1ELZ6|A0A4U1ELZ6_MONMO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Monodon monoceros OX=40151 GN=EI555_010818 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A4W2C1A7|A0A4W2C1A7_BOBOX Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos indicus x Bos taurus OX=30522 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A4X1U427|A0A4X1U427_PIG Proto-oncogene tyrosine-protein kinase receptor Ret OS=Sus scrofa OX=9823 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRHSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A4X1U649|A0A4X1U649_PIG Proto-oncogene tyrosine-protein kinase receptor Ret OS=Sus scrofa OX=9823 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRHSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A673TBL3|A0A673TBL3_SURSU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Suricata suricatta OX=37032 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A673TBM1|A0A673TBM1_SURSU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Suricata suricatta OX=37032 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A6B0RFM7|A0A6B0RFM7_9CETA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Bos mutus OX=72004 GN=E5288_WYG019359 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYNLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A6J2CLG4|A0A6J2CLG4_ZALCA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Zalophus californianus OX=9704 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A6P6C349|A0A6P6C349_PTEVA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pteropus vampyrus OX=132908 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKTGYMTVAVKMLKENASPNELRDLLSEFNLLKQVN\nHPNVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMEKPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLEKMMVKRRDYL\n&gt;tr|A0A6P6C3D5|A0A6P6C3D5_PTEVA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Pteropus vampyrus OX=132908 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKTGYMTVAVKMLKENASPNELRDLLSEFNLLKQVN\nHPNVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMEKPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLEKMMVKRRDYL\n&gt;tr|A0A6P6HD24|A0A6P6HD24_PUMCO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Puma concolor OX=9696 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A7J8GFA5|A0A7J8GFA5_ROUAE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rousettus aegyptiacus OX=9407 GN=HJG63_016583 PE=3 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPNELRDLLSEFNLLKQVN\nHPNVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRGSRNSNYL\nDNPDERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMEKPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLEKMMVKRRDYL\n&gt;tr|A0A7N5KJC5|A0A7N5KJC5_AILME Proto-oncogene tyrosine-protein kinase receptor Ret OS=Ailuropoda melanoleuca OX=9646 GN=RET PE=3 SV=2\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A811YYL9|A0A811YYL9_NYCPR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Nyctereutes procyonoides OX=34880 GN=NYPRO_LOCUS12321 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFQLKGKAGYTTVAVKMLKENASPSELRDLLSELNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEHAKYGSLRGFLRESRKAGPGSV---GSGGSRSSSYL\nDNPEERALTTGNLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSEGRIPVKWMAVESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKRGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADIGKDLEKMMVKNREYL\n&gt;tr|A0A811ZC71|A0A811ZC71_NYCPR Proto-oncogene tyrosine-protein kinase receptor Ret OS=Nyctereutes procyonoides OX=34880 GN=NYPRO_LOCUS19075 PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGSV---GSGGSRSSSYL\nDNPEERALTTGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSEGRIPVKWMAVESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKRGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADIGKDLEKMMVKNREYL\n&gt;tr|A0A8C0RNG4|A0A8C0RNG4_CANLF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Canis lupus familiaris OX=9615 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8C0TXR9|A0A8C0TXR9_CANLF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Canis lupus familiaris OX=9615 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A8D1M7Z5|A0A8D1M7Z5_PIG Proto-oncogene tyrosine-protein kinase receptor Ret OS=Sus scrofa OX=9823 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRHSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8D1SMX3|A0A8D1SMX3_PIG Proto-oncogene tyrosine-protein kinase receptor Ret OS=Sus scrofa OX=9823 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRHSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0A8I3PV09|A0A8I3PV09_CANLF Proto-oncogene tyrosine-protein kinase receptor Ret OS=Canis lupus familiaris OX=9615 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A9B0H3A6|A0A9B0H3A6_ODORO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Odobenus rosmarus divergens OX=9708 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0A9L0TGC7|A0A9L0TGC7_HORSE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Equus caballus OX=9796 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0AAD4Y0S5|A0AAD4Y0S5_OVIAM Proto-oncogene tyrosine-protein kinase receptor Ret OS=Ovis ammon polii OX=230172 GN=MG293_020669 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0AAW0JHD4|A0AAW0JHD4_MYOGA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Myodes glareolus OX=447135 GN=U0070_021328 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPGYV---GSGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHVYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0AB34GHJ1|A0AB34GHJ1_ESCRO Proto-oncogene tyrosine-protein kinase receptor Ret OS=Eschrichtius robustus OX=9764 GN=J1605_014116 PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|D2H6E6|D2H6E6_AILME Proto-oncogene tyrosine-protein kinase receptor Ret [Fragment] OS=Ailuropoda melanoleuca OX=9646 GN=PANDA_005545 PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|F6S7W7|F6S7W7_MACMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca mulatta OX=9544 GN=RET PE=3 SV=3\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|H9ZBZ9|H9ZBZ9_MACMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca mulatta OX=9544 GN=RET PE=2 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|H9ZC00|H9ZC00_MACMU Proto-oncogene tyrosine-protein kinase receptor Ret OS=Macaca mulatta OX=9544 GN=RET PE=2 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYL---GSGGSRNSSSL\nDHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|W5P1A8|W5P1A8_SHEEP Proto-oncogene tyrosine-protein kinase receptor Ret OS=Ovis aries OX=9940 GN=RET PE=3 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---G----RNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0ABI7WFU7|A0ABI7WFU7_FELCA Uncharacterized protein OS=Felis catus OX=9685 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0ABK0KWL2|A0ABK0KWL2_RAT Ret proto-oncogene OS=Rattus norvegicus OX=10116 GN=Ret PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPAYV---SSGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0ABM0HRK2|A0ABM0HRK2_CERSS Proto-oncogene tyrosine-protein kinase receptor Ret isoform X2 OS=Ceratotherium simum simum OX=73337 GN=LOC101401849 PE=4 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0ABM0LFP2|A0ABM0LFP2_MICOH Proto-oncogene tyrosine-protein kinase receptor Ret OS=Microtus ochrogaster OX=79684 GN=Ret PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRDSRKIGPGYV---GSGGSRNSSSL\nDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD\nVYEEDSYVKKSKGRIPVKWMAIESLFDHVYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0ABM2ENY1|A0ABM2ENY1_EQUPR Proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 OS=Equus przewalskii OX=9798 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVEATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKSRDYL\n&gt;tr|A0ABM3NUI2|A0ABM3NUI2_ACIJB Proto-oncogene tyrosine-protein kinase receptor Ret isoform X2 OS=Acinonyx jubatus OX=32536 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0ABM3SCF4|A0ABM3SCF4_BALAC Proto-oncogene tyrosine-protein kinase receptor Ret OS=Balaenoptera acutorostrata OX=9767 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASASELRDLLSEFNLLTQVS\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSRDSRNSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKEEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0ABM4YZ43|A0ABM4YZ43_VULVU Proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 OS=Vulpes vulpes OX=9627 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPHVIKLYGACSQD--GPLFLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRSSSYL\nDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYGLMLQCWKQEPDKRPVFADISKDLEKMMVKNRDYL\n&gt;tr|A0ABM5E203|A0ABM5E203_VICPA Proto-oncogene tyrosine-protein kinase receptor Ret OS=Vicugna pacos OX=30538 GN=RET PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASTSEMRDLQSEFNLLKQVN\nHPQVIKLYGACSQG--GPLLLIVEYAKYGSLRGFLRESRKAGPGYM---GSGDNRSSSYL\nDNPEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n&gt;tr|A0ABN8ZWN7|A0ABN8ZWN7_RANTA Uncharacterized protein OS=Rangifer tarandus platyrhynchus OX=3082113 GN=MRATA1EN1_LOCUS26358 PE=4 SV=1\nLVLGKTLGEGEFGKVVKATAFRLKGKAGYTTVAVKMLKENASPSELRDLLSEFNLLKQVN\nHPQVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKAGPGYV---GSGGSRNSSYL\nDNLEERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLSRD\nVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE\nRLFNLLKTGYRMERPDNCSEEMYSLMLQCWKQEPDKRPVFADISKDLDKMMVKSRDYL\n</code></pre> <p>Having the alignment ready, the B2BTools server can process this input file to return the biophysical profiles.</p> Explore the aligned backbone dynamics <p> DynaMine backbone dynamics for 50% identity aligned kinase domains </p> Explore the aligned disorder <p> DisoMine disorder propensities for 50% identity aligned kinase domains </p> Explore the aligned early folding events <p> EFoldMine early folding events for 50% identity aligned kinase domains </p> <p>Interactive results</p> <p>For further details:  Open the results on the B2BTools platoform.</p>"},{"location":"chapters/chapter_03/#36-connecting-online-resources","title":"3.6 Connecting online resources","text":"<p>For a selected protein, a set of \u201cexternal resources\u201d will be shown in the left navigation bar if the header is recognised as a UniProt entry.</p> <p>Hands-on: Finding phosphosites on Scop3P for P07949</p> <ol> <li>Look for all the modified kinases on Scop3P at https://iomics.ugent.be/scop3p/search?q=kinase.</li> <li>Find and select <code>P07949</code> from the list. </li> </ol> <p>Given the B2BTools page also includes the direct link, you can proceed with these steps: </p> <p>1 Select the <code>P07949</code> protein in the dropdown selector. 1. Clicking on the \u201cFind PTMs on Scop3P\u201d redirects you to the entry page on that resource: https://iomics.ugent.be/scop3p/index?protein=P07949.</p> Solution <p> P07949 on Scop3P </p> <p>\ud83e\udd6a LUNCH BREAK</p> <p>Time to grab a coffee or tea. We\u2019ll be back in one and a half hour\u2026</p> <p>To be continued: : Go to chapter 4</p> <p>Next chapter explains how to explore the modifications (PTMs).</p> <ol> <li> <p>Jose Gavalda-Garcia, Adri\u00e1n D\u00edaz, and Wim Vranken. Bio2byte tools deployment as a python package and galaxy tool to predict protein biophysical properties. Bioinformatics (Oxford, England), 40(9):btae543, September 2024. URL: https://europepmc.org/articles/PMC11873786, doi:10.1093/bioinformatics/btae543.\u00a0\u21a9</p> </li> <li> <p>Elisa Cilia, Rita Pancsa, Peter Tompa, Tom Lenaerts, and Wim F Vranken. From protein sequence to dynamics and disorder with dynamine. Nature communications, 4:2741, 2013. URL: https://doi.org/10.1038/ncomms3741, doi:10.1038/ncomms3741.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Codic\u00e8, Francesco Tabaro, and Wim Vranken. Prediction of disordered regions in proteins with recurrent neural networks and protein dynamics. Journal of Molecular Biology, 434(12):167579, 2022. URL: https://www.sciencedirect.com/science/article/pii/S0022283622001590, doi:https://doi.org/10.1016/j.jmb.2022.167579.\u00a0\u21a9</p> </li> <li> <p>Daniele Raimondi, Gabriele Orlando, Rita Pancsa, Taushif Khan, and Wim F Vranken. Exploring the sequence-based prediction of folding initiation sites in proteins. Scientific reports, 7(1):8826, August 2017. URL: https://europepmc.org/articles/PMC5562875, doi:10.1038/s41598-017-08366-3.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Alexandra Silva, Sandra Macedo-Ribeiro, Daniele Raimondi, and Wim Vranken. Accurate prediction of protein beta-aggregation with generalized statistical potentials. Bioinformatics, 36(7):2076\u20132081, 12 2019. URL: https://doi.org/10.1093/bioinformatics/btz912, arXiv:https://academic.oup.com/bioinformatics/article-pdf/36/7/2076/50670159/bioinformatics_36_7_2076.pdf, doi:10.1093/bioinformatics/btz912.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Tabaro, Francesco Codic\u00e8, Yves Moreau, and Wim F Vranken. Computational identification of prion-like rna-binding proteins that form liquid phase-separated condensates. Bioinformatics, 35(22):4617\u20134623, 04 2019. URL: https://doi.org/10.1093/bioinformatics/btz274, arXiv:https://academic.oup.com/bioinformatics/article-pdf/35/22/4617/48978636/bioinformatics_35_22_4617.pdf, doi:10.1093/bioinformatics/btz274.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Luciano Porto Kagami, and Wim F Vranken. Shiftcrypt: a web server to understand and biophysically align proteins through their nmr chemical shift values. Nucleic Acids Research, 48(W1):W36\u2013W40, 05 2020. URL: https://doi.org/10.1093/nar/gkaa391, arXiv:https://academic.oup.com/nar/article-pdf/48/W1/W36/33432832/gkaa391.pdf, doi:10.1093/nar/gkaa391.\u00a0\u21a9</p> </li> <li> <p>Luciano Porto Kagami, Gabriele Orlando, Daniele Raimondi, Francois Ancien, Bhawna Dixit, Jose Gavald\u00e1-Garc\u00eda, Pathmanaban Ramasamy, Joel Roca-Mart\u00ednez, Konstantina Tzavella, and Wim Vranken. B2btools: online predictions for protein biophysical features and their conservation. Nucleic Acids Research, 49(W1):W52\u2013W59, 05 2021. URL: https://doi.org/10.1093/nar/gkab425, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W52/38842326/gkab425.pdf, doi:10.1093/nar/gkab425.\u00a0\u21a9</p> </li> </ol>"},{"location":"chapters/chapter_04/","title":"4. Working with post-translational modifications","text":""},{"location":"chapters/chapter_04/#41-why-scop3p-as-the-go-to-for-modifications","title":"4.1 Why Scop3P as the go-to for modifications ?","text":"<p>Protein phosphorylation is a key post-translational modification involved in many biological processes and is strongly associated with human diseases such as cancer and metabolic disorders.</p> <p>Accurate identification, annotation, and functional analysis of phosphorylation sites (phosphosites) are therefore essential to understand their biological roles. Phosphosites are mainly studied using phosphoproteomics approaches, which have produced large amounts of publicly available data. Several resources have been developed to collect and organize phosphosite information, but most of them focus primarily on protein sequences and basic site-level metadata.</p> <p>Other resources often contain false positives and doesn\u2019t include the experimental metadata (localization probability, FDR, database used for searching)</p>  Mass-spec figure 1   Mass-spec figure 2   Mass-spec figure 3  <p>What is often missing from these resources is biological and structural context, including mapping to protein structures, experimental provenance, and biophysical annotations.</p>  Protein coverage  <p>ScoP3P addresses this gap by integrating protein sequences (UniProtKB/Swiss-Prot), structural data (PDB), and uniformly reprocessed phosphoproteomics datasets (PRIDE) to annotate all known human phosphosites. In addition, each phosphoprotein is enriched with per-residue biophysical annotations, including structural propensity, solvent accessibility, disorder probability, and early folding regions.</p> <p>ScoP3P, available at https://iomics.ugent.be/scop3p, provides a dedicated platform for the visualization and analysis of phosphosites and supports the study of phosphosite\u2013structure\u2013function relationships.</p> <p>Chapter questions</p> <ol> <li>How should Scop3P information be interpreted for a given protein target?</li> <li>How can PTMs be linked to structural data, such as predicted models or experimental structures from the PDB?</li> </ol>"},{"location":"chapters/chapter_04/#42-exploring-experimentally-supported-ptms","title":"4.2 Exploring experimentally supported PTMs","text":""},{"location":"chapters/chapter_04/#421-via-the-webserver","title":"4.2.1 Via the webserver","text":"<p>Hands-on: Website usage</p> <ol> <li>Explore the PTM map over the sequence length using lollypop plot.</li> <li>Link the lollypop information to the structural representation.<ol> <li>Toggle between experimental and predicted structures.</li> <li>Change visualisation properties such as style and colour.</li> </ol> </li> <li>Find the modification metadata from the summary table.</li> <li>Explore the biophysical circular plot.<ol> <li>Mouse over to view the values.</li> </ol> </li> <li>From the peptide table, explore the phospho-sites identified by mass spectrometry experiments (project information, species, tissue/cell type).<ol> <li>Hint: you can also visualise the original spectra using the USI link.</li> </ol> </li> <li>From the structures table, explore the modifications related to experimental structures.<ol> <li>Hint: you can explore <ul> <li>The secondary-structure information (conservation, surface accessibility)</li> <li>Do you see multiple conformational state for the same protein ?</li> </ul> </li> </ol> </li> <li>From the mutations table, explore the natural variant and the disease context.</li> </ol> Solution <p>Exploring the modifications:</p> <p>  Linking the lollypop information to the structural representation  </p> <p>Viewing the phospho projects:</p> <p>  explore the phospho-sites identified by mass spectrometry experiments  </p> <p>Structures and mutations:</p> <p>  Exploring the modifications related to experimental structures and diseases  </p>"},{"location":"chapters/chapter_04/#423-via-the-rest-api","title":"4.2.3 Via the REST API","text":"<p>Hands-on: REST API usage</p> <p>For this activity open this interactive notebook: <code>Scop3P_API.ipynb</code>:   </p> <ol> <li>Fetch protein sequence from UniProt</li> <li>Fetch modifications from Scop3P</li> <li>Parse the data</li> <li>Explore the functional scores</li> </ol> Solution <ol> <li>Open the Colab Notebook.</li> <li>Install the dependencies</li> <li>Change the \u201cTarget protein\u201d to \u201cP07949\u201d</li> <li>Fetch the canonical sequence from UniProt REST API</li> <li>Fetch the modifications from Scop3P REST API</li> <li>Run the data parsing code cells</li> <li>Run the \u201cFunctional scores\u201d cell to visualise the plot</li> </ol> View functional scores <p>Plot extracted from the Colab notebook:</p> <p>  P07949 functional sites  </p> <p>\u2615\ufe0f COFFEE BREAK</p> <p>Time to grab a coffee or tea. We\u2019ll be back in ten minutes\u2026</p> <p>To be continued: Go to chapter 5</p> <p>Next chapter explains how to connect PTMs to biophysical profiles.</p>"},{"location":"chapters/chapter_05/","title":"5. Combining PTM annotations to biophysical properties","text":"<p>Chapter questions</p> <ol> <li>How can biophysical predictions help to interpret the functional impact of phosphosites?</li> <li>How to evaluate the impact of mutations using these tools?</li> </ol>"},{"location":"chapters/chapter_05/#51-structural-and-biophysical-interpretation-of-ptms-and-mutations","title":"5.1 Structural and biophysical interpretation of PTMs and mutations","text":"<p>This activity gives an overview of exploring PTMs, mutations, biophysical properties on protein structures. </p> <p>Hands-on: Structural and biophysical interpretation of PTMs and mutations</p> <p>For this activity open the interactive notebook here: </p> Notebook (JupyterLab) Interactive app (Voil\u00e0) <p>\u26a0\ufe0f Chrome users: Please open the Notebook (JupyterLab) link first to authenticate, then launch the Interactive app (Voil\u00e0).</p> <ol> <li>Fetch PTMs from Scop3P REST API</li> <li>Fetch diseases variants from UniProt REST API</li> <li>Map PTMs to experimental and predicted protein structures</li> <li>Predict the biophysical properties and visualise them on protein structures</li> <li>Explore protein structures as residue-interaction network (RIN)<ol> <li>Constructing the RINs </li> <li>Exploring PTMs and mutation on the network</li> </ol> </li> </ol> Solution <p>  Different results using the provided notebook  </p>"},{"location":"chapters/chapter_05/#52-visualize-the-experimental-peptide-coverage-on-protein-structures","title":"5.2 Visualize the experimental peptide coverage on protein structures","text":"<p>Hands-on: Peptide mapper</p> <p>For this activity open these interactive notebooks: </p> <ol> <li> <p>To fetch phospho peptides from Scop3P and map onto protein structures click one of the link below: </p> Notebook (JupyterLab) Interactive app (Voil\u00e0) </li> </ol> <p>\u26a0\ufe0f Chrome users: open the Notebook link first to authenticate, then launch the app.</p> <ol> <li> <p>To upload your own data (Peptide table) and visualize the peptides and modifications on protein structures click one of the link below: </p> Notebook (JupyterLab) Interactive app (Voil\u00e0) </li> </ol> <p>\u26a0\ufe0f Chrome users: open the Notebook link first to authenticate, then launch the app.</p> Solution for Peptide mapper.ipynb <p>Fetch phospho peptides from Scop3P and map onto protein structures:</p> <ol> <li>Open the notebook on Google Colab.</li> <li>Import the required packages.</li> <li>Follow the steps of the interactive form.<ol> <li>Enter the protein ID (ex: P07949) and click \u2018Load\u2019</li> <li>The app will let you choose between all peptides (\u2018All rows\u2019) and unique spans (the peptide ranges are merged)</li> <li>Map all petides on the AF structure using \u2018Map all\u2019 (shows the mass spec coverage of your protein)</li> <li>Alternatively click one or multiple peptides on peptide panel to see their structural mapping</li> <li>Hint:<ul> <li>Explore what the search function does!</li> </ul> </li> </ol> </li> </ol> <p>Example</p> <p> </p> Solution for Peptide_maper_fileupload.ipynb <p>Upload your own data (Peptide table) and gets a peptide file and visualize the peptides and modifications on protein structures</p> <ol> <li>Open the notebook on Google Colab.</li> <li>Import the required packages.</li> <li>Follow the steps of the interactive form.<ol> <li>Choose peptide file (tsv/tab delimkited text file)  and click \u2018Load file\u2019</li> <li>The app will autofill the columns using keywords or enter the column headers<ol> <li>(protein ID column name [ACC_ID], peptide seq column name [pep_seq] and the modified position column name [UP_POS]</li> </ol> </li> <li>Click \u2018Build mapping\u2019</li> <li>Select the protein from list for which you want to map the peptides (note: these proteins are identified in your sample)</li> <li>Map all petides on the AF structure using \u2018Map all\u2019 (shows the mass spec coverage of your protein)</li> <li>Alternatively click one or multiple peptides on peptide panel to see their structural mapping</li> <li>Hint:<ul> <li>Explore what the search function does! </li> </ul> </li> </ol> </li> </ol> <p>Example</p> <p> </p>"},{"location":"chapters/chapter_05/#53-comparative-biophysical-analysis-of-wild-type-and-variant-states","title":"5.3 Comparative biophysical analysis of wild-type and variant states","text":"<p>For this activity we will mutate three positions of P07949:</p> <ol> <li>Mutate the position 909: <code>S909P</code><ul> <li>Wild: Serine (SER, S)</li> <li>Variant: Proline (PRO, P)</li> </ul> </li> <li>Mutate the position 928: <code>Y928P</code><ul> <li>Wild: Tyrosine (TYR, Y)</li> <li>Variant: Proline (PRO, P)</li> </ul> </li> <li>Mutate the position 981: <code>Y981P</code><ul> <li>Wild: Tyrosine (TYR, Y)</li> <li>Variant: Proline (PRO, P)  </li> </ul> </li> </ol> Mutant sequence (FASTA) <p>This is an variant sequence in FASTA format for the three mutations (S909P, Y928P, Y981P):</p> <pre><code>&gt;sp|P07949| Mutated S909P Y928P Y981P\nMAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLL\nYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLD\nHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTS\nFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPNISVAY\nRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVM\nVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPA\nSGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLV\nLNRNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTY\nSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAE\nDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVA\nEEAGCPLSCAVSKRRLECEECGGLGSPTGRCEWRQGDGKGITRNFSTCSPS\nTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCF\nPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKF\nAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILED\nPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS\nPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL\nRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE\nMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRPQGRIPVKWM\nAIESLFDHIPTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR\nMERPDNCSEEMPRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAA\nSTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPG\nESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS\n</code></pre> <p> You could save the mutant as \u201cP07949_s909p_y928p_y981p.fasta\u201d in your working directory: </p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.kinase.fasta\n\u2514\u2500\u2500\u2500 P07949_s909p_y928p_y981p.fasta\n</code></pre>"},{"location":"chapters/chapter_05/#531-explore-the-effect-of-mutations-biophysical-inference","title":"5.3.1 Explore the effect of mutations (biophysical inference)","text":"<p>Hands-on: Explore the effect of mutations (biophysical inference)</p> <p>For this activity open the Jupyter Lab or interactive app here: </p> Notebook (JupyterLab) Interactive app (Voil\u00e0) <p>\u26a0\ufe0f Chrome users: open the Notebook link first to authenticate, then launch the app.</p> <ol> <li>Predict the biophysical properties for the wild type</li> <li>Predict the biophysical properties for the mutant <code>S909P Y928P Y981P</code></li> </ol> Solution <ol> <li>The notebook requires the positions to mutate (comma-separated values) and the amino acids (comma-separated values).</li> <li>Predict the biophysical properties for the mutations</li> <li>Compare the biophysical properties between the wild type and mutant sequences.</li> <li>Infer the impact of mutations.</li> </ol> <p>  Biophysics changes  </p>"},{"location":"chapters/chapter_05/#532-explore-the-effect-of-mutations-structural-inference","title":"5.3.2 Explore the effect of mutations (structural inference)","text":"<p>Regarding the coordinate files for the structures, the predicted model by AlphaFold can be accessed directly from the AlphaFold Protein Structure Database. </p> <p>Hands-on: Downloading the experimental and predicted models</p> <ol> <li>Download the experimental structure 6NJA for the phosphorylated kinase in PDB format (<code>6nja.pdb</code>)</li> <li>Download the experimental structure 2IVS for the non-phosphorylated kinase in PDB format (<code>2ivs.pdb</code>)</li> <li>Download the predicted structure AF-P07949-F1 for the AlphaFold model in PDB format (<code>AF-P07949-F1.pdb</code>)</li> <li>For the mutant and phospho structures, you will predict them in the next activity using AlphaFold Server.</li> </ol> Solution <p>For the experimental structure 6NJA:</p> <ol> <li>Visit the entry for 6NJA on the European Protein Data Bank: https://www.ebi.ac.uk/pdbe/entry/pdb/6nja</li> <li>Click on \u201cDownload file\u201d and select \u201cPDB file\u201d</li> </ol> <p>For the experimental structure 2IVS:</p> <ol> <li>Visit the entry for 2IVS on the European Protein Data Bank: https://www.ebi.ac.uk/pdbe/entry/pdb/2ivs</li> <li>Click on \u201cDownload file\u201d and select \u201cPDB file\u201d</li> </ol> <p>For the predicted structure:</p> <ol> <li>Visit the AlphaFold Protein Structure Database and query the canonical structure by UniProt ID.</li> <li>Download the structure in PDB format (<code>.pdb</code> extension) to your working environment.<ol> <li>The canonical predicted structure is available on https://alphafold.ebi.ac.uk/entry/AF-P07949-F1.</li> </ol> </li> </ol> <p> You should now have these files in your working directory: </p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.kinase.fasta\n\u2502\u2500\u2500\u2500 P07949_s909p_y928p_y981p.fasta\n\u2502\u2500\u2500\u2500 AF-P07949-F1-model_v6.pdb\n\u2502\u2500\u2500\u2500 6nja.pdb \n\u2514\u2500\u2500\u2500 2ivs.pdb\n</code></pre> <p>The next step is to predict the variant structures using AlphaFold 3 server.</p> <p>Google account required</p> <p>You must log in using a Google account to enqueue structural prediction jobs. By default, you can use your \u201c@gmail.com\u201d address.</p> <p>Hands-on: Predicting the variant structures using AlphaFold server</p> <ol> <li>Open the AlphaFold Server at https://alphafoldserver.com and log in using your Google Account. By default you are entitled with 30 jobs. </li> <li>Add the sequence for <code>P07949_S909P_Y928P_Y981P</code> in the \u201cServer\u201d form with a single copy. <ol> <li>Continue and preview the job to submit it as \u201cP07949_S909P_Y928P_Y981P\u201d.</li> </ol> </li> <li>Add the wild type sequence for <code>P07949</code> in the \u201cServer\u201d form<ol> <li>Add a \u201cPhosphoserine\u201d modification on the position 909.</li> <li>Add a \u201cO-Phospho-L-tyrosine\u201d modification on the position 928.</li> <li>Add a \u201cO-Phospho-L-tyrosine\u201d modification on the position 981.</li> <li>Continue and preview the job to submit it as \u201cP07949_modifications\u201d.</li> </ol> </li> <li>Download the <code>model_0</code> files after they are predicted.</li> <li>Convert the mmCIF files to PDB format using the convert tool \u201ccif2pdb\u201d.</li> </ol> Solution <p>Standard prediction:</p> <p>The enqueued job will be listed in the jobs table below the \u201cContinue and review job\u201d blue button. Once the job is completed, you can click on the job row to open the results page.</p> <p>From the results page you can download the model files in ZIP format to your working environment including structures and their associated confidence values:</p> <ul> <li>Five .cif files named fold_modelcif, where \u201c\u201d is the rank of the predicted structure. Structures are ranked from 0 to 4, where 0 has the highest confidence. The .cif files contain predicted structures in the mmCIF format. They can be viewed in any molecular viewer like PyMOL or ChimeraX.</li> <li>Five .json files named fold_summary_confidences.json, where \u201c\u201d is the rank of the predicted structure from 0 to 4. These .json files contain summaries of the confidence metrics for the predictions (see below for more details on confidence metrics).</li> <li>Five .json files named fold_full_data.json, where \u201c\u201d is the rank of the predicted structure from 0 to 4. These .json files contain detailed confidence metrics, such as full PAE data, for the predictions (see below for more on confidence metrics).</li> <li>A file named fold__job_request.json. This contains the inputs of the modelling job and could be used to re-run the job (for more details, see Advanced use of AlphaFold Server).</li> <li>A file named terms_of_use.md. This is a legal document detailing the terms of use for the predictions. </li> </ul> <p>Select the model_0 mmCIF file (<code>.cif</code>) to work with the model that has the highest confidence.</p> <p>Adding PTMs:</p> <ol> <li>Click on the \u201c\u2026\u201d button to show the contextual menu.</li> <li>Select \u201c+ PTMS\u201d to open the \u201cPost-Translational Modifications\u201d.</li> <li>Click on the position of interest to highlight it.</li> <li>Select from the list the type of modification</li> </ol> <p>  Biophysics changes  </p> <p> You should now have these files in your working directory: </p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.fasta\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.kinase.fasta\n\u2502\u2500\u2500\u2500 P07949_s909p_y928p_y981p.fasta\n\u2502\u2500\u2500\u2500 AF-P07949-F1-model_v6.pdb # AlphaFold model for P07949 in PDB format\n\u2502\u2500\u2500\u2500 6nja.pdb # Experimental structure for 6NJA in PDB format\n\u2502\u2500\u2500\u2500 2ivs.pdb # Experimental structure for 2IVS in PDB format\n\u2502\u2500\u2500\u2500 fold_p07949_modifications_model_0.cif # AlphaFold server prediction for phospho\n\u2502\u2500\u2500\u2500 fold_p07949_modifications_model_0.pdb # AlphaFold server prediction for phospho\n\u2502\u2500\u2500\u2500 fold_p07949_s909p_y928p_y981p.cif # AlphaFold server prediction for mutations\n\u2514\u2500\u2500\u2500 fold_p07949_s909p_y928p_y981p.pdb # AlphaFold server prediction for mutations\n</code></pre> <p>Now the files are ready to be processed, let\u2019s continue to the next activity.</p> <p>Hands-on: Structural inference</p> <p>For this activity open the Jupterlabl or interactive App here and go to Tab 6) TM-align:  </p> Notebook (JupyterLab) Interactive app (Voil\u00e0) <p>\u26a0\ufe0f Chrome users: Please open the Notebook (JupyterLab) link first to authenticate, then launch the Interactive app (Voil\u00e0).</p> <ol> <li>Aligning and exploring protein structures<ol> <li>predicted vs experimental</li> <li>phospho vs non-phospho</li> <li>mutated vs wild type</li> </ol> </li> </ol> Solution <ol> <li>Predicted vs Experimental (phospho)<ol> <li>Use the unmodified Alphafold model (<code>AF-P07949-F1.pdb</code>) vs 6NJA experimental structure (<code>6nja.pdb</code>)</li> </ol> </li> <li>Experimental phospho vs experimental non-phospho<ol> <li>6NJA experimental structure vs 2IVS experimental structure (<code>2ivs.pdb</code>)</li> </ol> </li> <li>Predicted Wild type vs predicted mutated<ol> <li>Use the unmodified Alphafold model (<code>AF-P07949-F1.pdb</code>) vs the AlphaFold server mutated structure (<code>P07949_S909P_Y928P_Y981P.pdb</code>)</li> </ol> </li> <li>Predicted Wild type vs predicted phospo<ol> <li>Use the unmodified Alphafold model (<code>AF-P07949-F1.pdb</code>) vs the AlphaFold server phospho structure (<code>P07949_modifications.pdb</code>)</li> </ol> </li> </ol> <p>\u2615\ufe0f COFFEE BREAK</p> <p>Time to grab a coffee or tea. We\u2019ll be back in ten minutes\u2026 Please stay for the closing session (feedback much appreciated)</p> <p>To conclude: : Go to chapter 5</p> <p>Next chapter wraps up all the learnings and hands on activities.</p>"},{"location":"chapters/chapter_06/","title":"6. Closing","text":"<p>In this final chapter, we summarize the main steps and concepts covered throughout the training. The course combined biophysical predictions, sequence analysis, structural context, and post-translational modification data to explore a biologically relevant protein in a reproducible and practical way.</p> <p>The workflow presented in this training is intended as a template that can be adapted to other proteins and research questions. Participants are encouraged to reuse and extend the presented approaches in their own projects.</p>"},{"location":"chapters/chapter_06/#61-lessons-learnt","title":"6.1 Lessons learnt","text":"<p>Throughout this training, we highlighted several practical and conceptual lessons, including:</p> <ul> <li>How biophysical predictions complement both sequence and structural based analyses  </li> <li>The value of multiple sequence alignments for identifying conserved and variable regions  </li> <li>The importance of structural and biophysical context when interpreting PTMs  </li> <li>The benefits and limitations of prediction-based approaches  </li> </ul> <p>These lessons aim to support more informed and critical use of computational tools in biological research.</p>"},{"location":"chapters/chapter_06/#62-take-home-messages","title":"6.2 Take-home messages","text":"<p>The key messages of this training can be summarized as follows:</p> <ul> <li>Biophysical profiles provide insight beyond primary sequence information  </li> <li>Integrating multiple data sources leads to more robust biological interpretation  </li> <li>Prediction tools are powerful but must be used with awareness of their assumptions  </li> <li>Reproducible workflows enable reuse and extension of analyses  </li> </ul> <p>These points are intended to guide future analyses and encourage thoughtful tool usage.</p>"},{"location":"chapters/chapter_06/#63-discussion-and-open-questions","title":"6.3 Discussion and open questions","text":"<p>This section is intended as a space for reflection, discussion, and feedback.</p> <p>Questions for you</p> <ol> <li>What parts of the course content were most useful or most challenging?</li> <li>Which steps or concepts would benefit from additional explanation or examples?</li> <li>How could this training be improved to better support your research needs?</li> <li>Do you have feedback on the usability, clarity, or limitations of the tools presented in this course?</li> </ol>"},{"location":"chapters/chapter_06/#64-files-structure","title":"6.4 Files structure","text":"<p>During this training the following files have been created and used:</p> <pre><code>./training-data-directory\n\u2502\u2500\u2500\u2500 P07949.fasta # Canonical protein sequence of P07949\n\u2502\u2500\u2500\u2500 P07949.90-similar.fasta # 90%-similarity sequences of P07949\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.fasta # Clustal-Omega MSA of 90%-similarity sequences\n\u2502\u2500\u2500\u2500 P07949.90-similar.msa.kinase.fasta # Clustal-Omega MSA of Kinase domain\n\u2502\u2500\u2500\u2500 P07949_s909p_y928p_y981p.fasta # Mutated canonical protein sequence with 3 mut.\n\u2502\u2500\u2500\u2500 AF-P07949-F1-model_v6.cif # AlphaFold model for P07949 in mmCIF format (optional)\n\u2502\u2500\u2500\u2500 AF-P07949-F1-model_v6.pdb # AlphaFold model for P07949 in PDB format\n\u2502\u2500\u2500\u2500 6nja.cif # Experimental structure for 6NJA in mmCIF format (optional)\n\u2502\u2500\u2500\u2500 6nja.pdb # Experimental structure for 6NJA in PDB format\n\u2502\u2500\u2500\u2500 2ivs.cif # Experimental structure for 2IVS in mmCIF format (optional)\n\u2502\u2500\u2500\u2500 2ivs.pdb # Experimental structure for 2IVS in PDB format\n\u2502\u2500\u2500\u2500 fold_p07949_modifications_model_0.cif # AlphaFold server prediction for phospho\n\u2502\u2500\u2500\u2500 fold_p07949_modifications_model_0.pdb # AlphaFold server prediction for phospho\n\u2502\u2500\u2500\u2500 fold_p07949_s909p_y928p_y981p.cif # AlphaFold server prediction for mutations\n\u2514\u2500\u2500\u2500 fold_p07949_s909p_y928p_y981p.pdb # AlphaFold server prediction for mutations\n</code></pre> <p>To follow up: : Go to next page</p> <p>Follow up page explains how to apply the same workflow to proteins of your own interest.</p>"},{"location":"chapters/references/","title":"References","text":"<ol> <li> <p>Daniele Raimondi, Gabriele Orlando, Rita Pancsa, Taushif Khan, and Wim F Vranken. Exploring the sequence-based prediction of folding initiation sites in proteins. Scientific reports, 7(1):8826, August 2017. URL: https://europepmc.org/articles/PMC5562875, doi:10.1038/s41598-017-08366-3.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Alexandra Silva, Sandra Macedo-Ribeiro, Daniele Raimondi, and Wim Vranken. Accurate prediction of protein beta-aggregation with generalized statistical potentials. Bioinformatics, 36(7):2076\u20132081, 12 2019. URL: https://doi.org/10.1093/bioinformatics/btz912, arXiv:https://academic.oup.com/bioinformatics/article-pdf/36/7/2076/50670159/bioinformatics_36_7_2076.pdf, doi:10.1093/bioinformatics/btz912.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Luciano Porto Kagami, and Wim F Vranken. Shiftcrypt: a web server to understand and biophysically align proteins through their nmr chemical shift values. Nucleic Acids Research, 48(W1):W36\u2013W40, 05 2020. URL: https://doi.org/10.1093/nar/gkaa391, arXiv:https://academic.oup.com/nar/article-pdf/48/W1/W36/33432832/gkaa391.pdf, doi:10.1093/nar/gkaa391.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Tabaro, Francesco Codic\u00e8, Yves Moreau, and Wim F Vranken. Computational identification of prion-like rna-binding proteins that form liquid phase-separated condensates. Bioinformatics, 35(22):4617\u20134623, 04 2019. URL: https://doi.org/10.1093/bioinformatics/btz274, arXiv:https://academic.oup.com/bioinformatics/article-pdf/35/22/4617/48978636/bioinformatics_35_22_4617.pdf, doi:10.1093/bioinformatics/btz274.\u00a0\u21a9</p> </li> <li> <p>Gabriele Orlando, Daniele Raimondi, Francesco Codic\u00e8, Francesco Tabaro, and Wim Vranken. Prediction of disordered regions in proteins with recurrent neural networks and protein dynamics. Journal of Molecular Biology, 434(12):167579, 2022. URL: https://www.sciencedirect.com/science/article/pii/S0022283622001590, doi:https://doi.org/10.1016/j.jmb.2022.167579.\u00a0\u21a9</p> </li> <li> <p>Jose Gavalda-Garcia, Adri\u00e1n D\u00edaz, and Wim Vranken. Bio2byte tools deployment as a python package and galaxy tool to predict protein biophysical properties. Bioinformatics (Oxford, England), 40(9):btae543, September 2024. URL: https://europepmc.org/articles/PMC11873786, doi:10.1093/bioinformatics/btae543.\u00a0\u21a9</p> </li> <li> <p>Elisa Cilia, Rita Pancsa, Peter Tompa, Tom Lenaerts, and Wim F Vranken. From protein sequence to dynamics and disorder with dynamine. Nature communications, 4:2741, 2013. URL: https://doi.org/10.1038/ncomms3741, doi:10.1038/ncomms3741.\u00a0\u21a9</p> </li> <li> <p>Luciano Porto Kagami, Gabriele Orlando, Daniele Raimondi, Francois Ancien, Bhawna Dixit, Jose Gavald\u00e1-Garc\u00eda, Pathmanaban Ramasamy, Joel Roca-Mart\u00ednez, Konstantina Tzavella, and Wim Vranken. B2btools: online predictions for protein biophysical features and their conservation. Nucleic Acids Research, 49(W1):W52\u2013W59, 05 2021. URL: https://doi.org/10.1093/nar/gkab425, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W52/38842326/gkab425.pdf, doi:10.1093/nar/gkab425.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Demet Turan, Natalia Tichshenko, Niels Hulstaert, Elien Vandermarliere, Wim Vranken, and Lennart Martens. Scop3p: a comprehensive resource of human phosphosites within their full context. Journal of proteome research, 19(8):3478\u20143486, August 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00306, doi:10.1021/acs.jproteome.0c00306.\u00a0\u21a9</p> </li> <li> <p>Pathmanaban Ramasamy, Jasper Zuallaert, Lennart Martens, and Wim F Vranken. Assessing the relation between protein phosphorylation, alphafold3 models, and conformational variability. Protein science : a publication of the Protein Society, 35(1):e70376, January 2026. URL: https://europepmc.org/articles/PMC12723721, doi:10.1002/pro.70376.\u00a0\u21a9</p> </li> <li> <p>David Sehnal, Sebastian Bittrich, Mandar Deshpande, Radka Svobodov\u00e1, Karel Berka, V\u00e1clav Bazgier, Sameer Velankar, Stephen K Burley, Jaroslav Ko\u010da, and Alexander S Rose. Mol* viewer: modern web app for 3d visualization and analysis of large biomolecular structures. Nucleic Acids Research, 49(W1):W431\u2013W437, 05 2021. URL: https://doi.org/10.1093/nar/gkab314, arXiv:https://academic.oup.com/nar/article-pdf/49/W1/W431/38842088/gkab314.pdf, doi:10.1093/nar/gkab314.\u00a0\u21a9</p> </li> <li> <p>Adam Midlik, Sebastian Bittrich, Jennifer R Fleming, Sreenath Nair, Sameer Velankar, Stephen K Burley, Jasmine Y Young, Brinda Vallat, and David Sehnal. Molviewspec: a mol* extension for describing and sharing molecular visualizations. Nucleic Acids Research, 53(W1):W408\u2013W414, 05 2025. URL: https://doi.org/10.1093/nar/gkaf370, arXiv:https://academic.oup.com/nar/article-pdf/53/W1/W408/63067309/gkaf370.pdf, doi:10.1093/nar/gkaf370.\u00a0\u21a9</p> </li> <li> <p>The UniProt Consortium. Uniprot: the universal protein knowledgebase in 2025. Nucleic Acids Research, 53(D1):D609\u2013D617, 11 2024. URL: https://doi.org/10.1093/nar/gkae1010, arXiv:https://academic.oup.com/nar/article-pdf/53/D1/D609/60719276/gkae1010.pdf, doi:10.1093/nar/gkae1010.\u00a0\u21a9</p> </li> <li> <p>Geert van Geest, Elin Kronander, Jose Alejandro Romero Herrera, Nadja \u017dlender, ELIXIR Training Coordination Team, and Alexia Cardona. The elixir training lesson template - developing training together. May 2023. URL: https://doi.org/10.5281/zenodo.7913092, doi:10.5281/zenodo.7913092.\u00a0\u21a9</p> </li> </ol>"}]}